{"initialLink":"https://www.theatlantic.com/health/archive/2022/10/americas-covid-booster-rates-are-a-bad-sign-for-winter/671860/","sanitizedLink":"https://www.theatlantic.com/health/archive/2022/10/americas-covid-booster-rates-are-a-bad-sign-for-winter/671860/","finalLink":"https://www.theatlantic.com/health/archive/2022/10/americas-covid-booster-rates-are-a-bad-sign-for-winter/671860/","htmlEmbed":"<script>window.contexterSetup=window.contexterSetup||function(){window.contexterSetupComplete=!0;class ContexterLink extends HTMLAnchorElement{constructor(){super()}connectedCallback(){this.setAttribute(\"target\",\"_blank\")}}customElements.define(\"contexter-link\",ContexterLink,{extends:\"a\"}),customElements.define(\"contexter-inner\",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className=\"contexter-box__inner\"}}),customElements.define(\"contexter-thumbnail\",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className=\"contexter-box__thumbnail\"}}),customElements.define(\"contexter-byline\",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className=\"contexter-box__byline\"}}),customElements.define(\"contexter-keywordset\",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className=\"contexter-box__keywordset\"}}),customElements.define(\"contexter-linkset\",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className=\"contexter-box__linkset\"}}),customElements.define(\"contexter-meta\",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className=\"contexter-box__meta\"}}),customElements.define(\"contexter-summary\",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className=\"p-summary entry-summary\"}}),customElements.define(\"contexter-box-head\",class extends HTMLElement{constructor(){super()}connectedCallback(){this.className=\"contexter-box__head\"}}),customElements.define(\"contexter-box-inner\",class extends HTMLElement{constructor(){super()}connectedCallback(){}});class ContexterBox extends HTMLElement{constructor(){super(),this.first=!0,this.shadow=this.attachShadow({mode:\"open\"})}connectedCallback(){if(this.first){this.first=!1;var style=document.createElement(\"style\"),lightDomStyle=(style.innerHTML=`:host {--background: #f5f6f7;--border: darkblue;--blue: #0000ee;--font-color: black;--inner-border: black;font-family: Franklin,Arial,Helvetica,sans-serif;font-size: 14px;background: var(--background);width: 600px;color: var(--font-color);min-height: 90px;display: block;padding: 8px;border: 1px solid var(--border);cursor: pointer;box-sizing: border-box;margin: 6px;contain: content;margin: 6px auto;}// can only select top-level nodes with slotted::slotted(*) {max-width: 100%;display:block;}::slotted([slot=thumbnail]) {max-width: 100%;display:block;}::slotted([slot=header]) {width: 100%;font-size: 1.25rem;font-weight: bold;display:block;margin-bottom: 6px;}::slotted([slot=author]) {max-width: 50%;font-size: 12px;display:inline-block;float: left;}::slotted([slot=time]) {max-width: 50%;font-size: 12px;display:inline-block;float: right;}::slotted([slot=summary]) {width: 100%;margin-top: 6px;padding: 10px 2px;border-top: 1px solid var(--inner-border);font-size: 15px;display:inline-block;margin-bottom: 6px;}contexter-meta {height: auto;margin-bottom: 4px;width: 100%;display: grid;position: relative;min-height: 16px;grid-template-columns: repeat(2, 1fr);}::slotted([slot=keywords]) {width: 80%;padding: 2px 4px;border-top: 1px solid var(--inner-border);font-size: 11px;display: block;float: right;font-style: italic;text-align: right;grid-column: 2/2;grid-row: 1;align-self: end;justify-self: end;}::slotted([slot=keywords]):empty {border-top: 0px solid var(--inner-border);}::slotted([slot=archive-link]) {font-size: 1em;display: inline;}::slotted([slot=archive-link])::after {content: \"|\";display: inline;color: var(--font-color);text-decoration: none;margin: 0 .5em;}::slotted([slot=read-link]) {font-size: 1em;display: inline;}contexter-linkset {width: 80%;padding: 2px 4px;font-size: 13px;float: left;font-weight: bold;grid-row: 1;grid-column: 1/2;align-self: end;justify-self: start;}/* Extra small devices (phones, 600px and down) */@media only screen and (max-width: 600px) {:host {width: 310px;}}/* Small devices (portrait tablets and large phones, 600px and up) */@media only screen and (min-width: 600px) {...}/* Medium devices (landscape tablets, 768px and up) */@media only screen and (min-width: 768px) {...}/* Large devices (laptops/desktops, 992px and up) */@media only screen and (min-width: 992px) {...}/* Extra large devices (large laptops and desktops, 1200px and up) */@media only screen and (min-width: 1200px) {...}@media (prefers-color-scheme: dark){:host {--background: #354150;--border: #1f2b37;--blue: #55b0ff;--font-color: #ffffff;--inner-border: #787a7c;background: var(--background);border: 1px solid var(--border)}}`,document.createElement(\"style\"));lightDomStyle.innerHTML=`contexter-box {contain: content;}contexter-box .read-link {font-weight: bold;}contexter-box a {color: #0000ee;}contexter-box img {width: 100%;border: 0;padding: 0;margin: 0;}/* Extra small devices (phones, 600px and down) */@media only screen and (max-width: 600px) {...}/* Small devices (portrait tablets and large phones, 600px and up) */@media only screen and (min-width: 600px) {...}/* Medium devices (landscape tablets, 768px and up) */@media only screen and (min-width: 768px) {...}/* Large devices (laptops/desktops, 992px and up) */@media only screen and (min-width: 992px) {...}/* Extra large devices (large laptops and desktops, 1200px and up) */@media only screen and (min-width: 1200px) {...}@media (prefers-color-scheme: dark){contexter-box a {color: #55b0ff;}}`,this.appendChild(lightDomStyle),this.shadow.appendChild(style);const innerContainer=document.createElement(\"contexter-box-inner\"),innerSlotThumbnail=(this.shadow.appendChild(innerContainer),document.createElement(\"slot\")),innerSlotHeader=(innerSlotThumbnail.name=\"thumbnail\",innerContainer.appendChild(innerSlotThumbnail),document.createElement(\"slot\")),innerSlotAuthor=(innerSlotHeader.name=\"header\",innerContainer.appendChild(innerSlotHeader),document.createElement(\"slot\")),innerSlotTime=(innerSlotAuthor.name=\"author\",innerContainer.appendChild(innerSlotAuthor),document.createElement(\"slot\")),innerSlotSummary=(innerSlotTime.name=\"time\",innerContainer.appendChild(innerSlotTime),document.createElement(\"slot\")),metaContainer=(innerSlotSummary.name=\"summary\",innerContainer.appendChild(innerSlotSummary),document.createElement(\"contexter-meta\")),innerSlotInfo=(innerContainer.appendChild(metaContainer),document.createElement(\"slot\")),linkContainer=(innerSlotInfo.name=\"keywords\",metaContainer.appendChild(innerSlotInfo),document.createElement(\"contexter-linkset\")),innerSlotArchiveLink=(metaContainer.appendChild(linkContainer),document.createElement(\"slot\")),innerSlotReadLink=(innerSlotArchiveLink.name=\"archive-link\",linkContainer.appendChild(innerSlotArchiveLink),document.createElement(\"slot\"));innerSlotReadLink.name=\"read-link\",linkContainer.appendChild(innerSlotReadLink),this.className=\"contexter-box\",this.onclick=e=>{if(!e.target.className.includes(\"read-link\")&&!e.target.className.includes(\"title-link\")){const mainLinks=this.querySelectorAll(\"a.main-link\");mainLinks[0].click()}}}}}customElements.define(\"contexter-box\",ContexterBox)},window.contexterSetupComplete||window.contexterSetup();</script><contexter-box class=\"link-card h-entry hentry\" itemscope=\"\" itemtype=\"https://schema.org/CreativeWork\"><contexter-thumbnail class=\"thumbnail\" slot=\"thumbnail\"></contexter-thumbnail><contexter-box-head slot=\"header\" class=\"p-name entry-title\" itemprop=\"headline\"><contexter-box-head slot=\"header\" class=\"p-name entry-title\" itemprop=\"headline\"><a is=\"contexter-link\" href=\"https://www.theatlantic.com/health/archive/2022/10/americas-covid-booster-rates-are-a-bad-sign-for-winter/671860/\" itemprop=\"url\">It’s a Bad Time to Be a Booster Slacker</a></contexter-box-head></contexter-box-head><contexter-byline class=\"p-author author\" slot=\"author\"><span class=\"p-name byline\" rel=\"author\" itemprop=\"author\">Yasmin Tayag</span></contexter-byline><time class=\"dt-published published\" slot=\"time\" itemprop=\"datePublished\" datetime=\"2022-10-26T11:26:26.000Z\">10/26/2022</time><contexter-summary class=\"p-summary entry-summary\" itemprop=\"abstract\" slot=\"summary\"><p>Americans aren’t getting the new bivalent COVID shot. What does that mean for the looming winter wave?</p></contexter-summary><contexter-keywordset itemprop=\"keywords\" slot=\"keywords\"><span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">new COVID boosters</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">fall booster rollout</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">new booster</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">late September</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">much America’s immunological guardrails</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">early September</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">booster uptake</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">bivalent boosters</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">immune system</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">booster-eligible people</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">best chance</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">severe illness</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">original vaccines</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">new infection</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">coming months</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">America’s booster campaign</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">vulnerable groups</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">original SARS-CoV-2 virus</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">six-packs of pumpkin beer</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">Omicron causes</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">flu vaccine</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">community centers</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">pandemic problems</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">low numbers</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">North America</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">big difference</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">best thing</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">respiratory diseases</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">secondary effect</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">recent years</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">new Omicron offshoots</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">combination of these factors</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">White House COVID-19 response coordinator</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">people</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">new shots</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">lot of people</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">healthy people</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">vaccines</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">Advisory Committee</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">recent survey</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">latest booster</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">bivalent booster</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">United States</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">apple orchards</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">press conference</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">public-health expert</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">past year</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">Western Europe</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">short term</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">social media</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">health</span>, <span rel=\"category tag\" class=\"p-category\" itemprop=\"keywords\">Health</span></contexter-keywordset><a is=\"contexter-link\" href=\"https://www.theatlantic.com/health/archive/2022/10/americas-covid-booster-rates-are-a-bad-sign-for-winter/671860/\" class=\"read-link main-link\" itemprop=\"sameAs\" slot=\"read-link\">Read</a></contexter-box>","linkId":"b4ee13f75f413862731444135dd52650def07bec","data":{"originalLink":"https://www.theatlantic.com/health/archive/2022/10/americas-covid-booster-rates-are-a-bad-sign-for-winter/671860/","sanitizedLink":"https://www.theatlantic.com/health/archive/2022/10/americas-covid-booster-rates-are-a-bad-sign-for-winter/671860/","canonical":"https://www.theatlantic.com/health/archive/2022/10/americas-covid-booster-rates-are-a-bad-sign-for-winter/671860/","htmlText":"<!DOCTYPE html><html lang=\"en\" dir=\"ltr\"><head><meta charSet=\"utf-8\"/><meta name=\"viewport\" content=\"width=device-width,initial-scale=1\"/><link rel=\"icon\" href=\"https://cdn.theatlantic.com/_next/static/images/favicon-3888b0e329526a975703e3059a02b92d.ico\"/><link rel=\"apple-touch-icon\" href=\"https://cdn.theatlantic.com/_next/static/images/apple-touch-icon-default-b504d70343a9438df64c32ce339c7ebc.png\"/><link rel=\"apple-touch-icon\" sizes=\"76x76\" href=\"https://cdn.theatlantic.com/_next/static/images/apple-touch-icon-76x76-d5accc11b8265af76495fbfa9d38dd3b.png\"/><link rel=\"apple-touch-icon\" sizes=\"120x120\" href=\"https://cdn.theatlantic.com/_next/static/images/apple-touch-icon-120x120-419ba228184c040a691628d3dd82c206.png\"/><link rel=\"apple-touch-icon\" sizes=\"152x152\" href=\"https://cdn.theatlantic.com/_next/static/images/apple-touch-icon-152x152-aafde20dd981a38fcd549b29b2b3b785.png\"/><meta name=\"application-name\" content=\"theatlantic\"/><meta name=\"msapplication-TileColor\" content=\"#FFFFFF\"/><meta name=\"msapplication-TileImage\" content=\"https://cdn.theatlantic.com/_next/static/images/apple-touch-icon-default-b504d70343a9438df64c32ce339c7ebc.png\"/><meta property=\"og:site_name\" content=\"The Atlantic\"/><meta property=\"og:locale\" content=\"en_US\"/><meta property=\"fb:admins\" content=\"577048155,17301937\"/><meta property=\"fb:app_id\" content=\"100770816677686\"/><meta property=\"fb:pages\" content=\"29259828486,1468531833474495,1061579677251147,457711054591520,370457103090695,1631141167169115,148681772342453,1510507419185410,128344747344340,128377530562508,236061986423933\"/><meta name=\"p:domain_verify\" content=\"68e1a0361a557708fefc992f3309ed70\"/><meta name=\"twitter:site\" content=\"@theatlantic\"/><meta name=\"twitter:domain\" content=\"theatlantic.com\"/><script type=\"application/ld+json\">{\"@context\":\"https://schema.org\",\"@type\":\"WebSite\",\"name\":\"The Atlantic\",\"url\":\"https://www.theatlantic.com\",\"inLanguage\":\"en-US\",\"issn\":\"1072-7825\",\"potentialAction\":{\"@type\":\"SearchAction\",\"target\":\"https://www.theatlantic.com/search/?q={q}\",\"query-input\":\"required name=q\"}}</script><script type=\"application/ld+json\">{\"@context\":\"https://schema.org\",\"@type\":\"Organization\",\"@id\":\"https://www.theatlantic.com/#publisher\",\"name\":\"The Atlantic\",\"url\":\"https://www.theatlantic.com\",\"logo\":{\"@type\":\"ImageObject\",\"width\":{\"@type\":\"QuantitativeValue\",\"unitCode\":\"E37\",\"value\":224},\"height\":{\"@type\":\"QuantitativeValue\",\"unitCode\":\"E37\",\"value\":224},\"url\":\"https://cdn.theatlantic.com/assets/media/files/atlantic-logo--224x224.png\"},\"sameAs\":[\"https://www.facebook.com/TheAtlantic\",\"https://twitter.com/theatlantic\"]}</script><style id=\"_vis_opt_path_hide\">#paywall,#nonMeteredNudge,#gate {opacity:0;}</style><title>America’s COVID-Booster Rates Are a Bad Sign for Winter - The Atlantic</title><meta name=\"description\" content=\"Americans aren’t getting the new bivalent COVID shot. What does that mean for the looming winter wave?\"/><meta property=\"krux:title\" content=\"America’s COVID-Booster Rates Are a Bad Sign for Winter - The Atlantic\"/><meta property=\"krux:description\" content=\"Americans aren’t getting the new bivalent COVID shot. What does that mean for the looming winter wave?\"/><link rel=\"canonical\" href=\"https://www.theatlantic.com/health/archive/2022/10/americas-covid-booster-rates-are-a-bad-sign-for-winter/671860/\"/><link rel=\"image_src\" href=\"https://cdn.theatlantic.com/thumbor/V0abThj5aTxkiLt_4gWCHjDGwk0=/0x5:3996x2086/1200x625/media/img/mt/2022/10/original-5/original.jpg\"/><meta name=\"author\" content=\"Yasmin Tayag\"/><link rel=\"ia:markup_url\" href=\"https://www.theatlantic.com/facebook-instant/article/671860/\"/><meta property=\"article:publisher\" content=\"https://www.facebook.com/TheAtlantic/\"/><meta property=\"article:opinion\" content=\"false\"/><meta property=\"article:content_tier\" content=\"metered\"/><meta property=\"article:tag\" content=\"health\"/><meta property=\"article:section\" content=\"Health\"/><meta property=\"article:published_time\" content=\"2022-10-25T18:27:00Z\"/><meta property=\"article:modified_time\" content=\"2022-10-26T11:26:26Z\"/><meta name=\"robots\" content=\"index, follow, max-image-preview:large\"/><meta property=\"og:title\" content=\"It’s a Bad Time to Be a Booster Slacker\"/><meta property=\"og:description\" content=\"Americans aren’t getting the new bivalent COVID shot. What does that mean for the looming winter wave?\"/><meta property=\"og:url\" content=\"https://www.theatlantic.com/health/archive/2022/10/americas-covid-booster-rates-are-a-bad-sign-for-winter/671860/\"/><meta property=\"og:type\" content=\"article\"/><meta property=\"og:image\" content=\"https://cdn.theatlantic.com/thumbor/V0abThj5aTxkiLt_4gWCHjDGwk0=/0x5:3996x2086/1200x625/media/img/mt/2022/10/original-5/original.jpg\"/><meta property=\"twitter:card\" content=\"summary_large_image\"/><meta name=\"FacebookShareMessage\" content=\"America&#x27;s bivalent-booster campaign has not been going according to plan. Will that make the inevitable winter COVID wave even worse? @yeahyeahyasmin investigates:\"/><meta name=\"TwitterShareMessage\" content=\"America&#x27;s bivalent-booster campaign has not been going according to plan. Will that make the inevitable winter COVID wave even worse? @yeahyeahyasmin investigates:\"/><link rel=\"alternate\" type=\"application/rss+xml\" title=\"The Atlantic\" href=\"/feed/all/\"/><link rel=\"alternate\" type=\"application/rss+xml\" title=\"Best of The Atlantic\" href=\"/feed/best-of/\"/><meta name=\"referrer\" content=\"unsafe-url\"/><meta name=\"apple-mobile-web-app-capable\" content=\"yes\"/><meta name=\"apple-mobile-web-status-bar-style\" content=\"black\"/><meta name=\"apple-mobile-web-app-title\" content=\"The Atlantic\"/><meta name=\"keywords\" content=\"new COVID boosters, fall booster rollout, new booster, late September, much America’s immunological guardrails, early September, booster uptake, bivalent boosters, immune system, booster-eligible people, best chance, severe illness, original vaccines, new infection, coming months, America’s booster campaign, vulnerable groups, original SARS-CoV-2 virus, six-packs of pumpkin beer, Omicron causes, flu vaccine, community centers, pandemic problems, low numbers, North America, big difference, best thing, respiratory diseases, secondary effect, recent years, new Omicron offshoots, combination of these factors, White House COVID-19 response coordinator, people, new shots, lot of people, healthy people, vaccines, Advisory Committee, recent survey, latest booster, bivalent booster, United States, apple orchards, press conference, public-health expert, past year, Western Europe, short term, social media\" itemID=\"#keywords\"/><meta name=\"news_keywords\" content=\"new COVID boosters, fall booster rollout, new booster, late September, much America’s immunological guardrails, early September, booster uptake, bivalent boosters, immune system, booster-eligible people, best chance, severe illness, original vaccines, new infection, coming months, America’s booster campaign, vulnerable groups, original SARS-CoV-2 virus, six-packs of pumpkin beer, Omicron causes, flu vaccine, community centers, pandemic problems, low numbers, North America, big difference, best thing, respiratory diseases, secondary effect, recent years, new Omicron offshoots, combination of these factors, White House COVID-19 response coordinator, people, new shots, lot of people, healthy people, vaccines, Advisory Committee, recent survey, latest booster, bivalent booster, United States, apple orchards, press conference, public-health expert, past year, Western Europe, short term, social media\"/><meta name=\"sailthru.title\" content=\"It’s a Bad Time to Be a Booster Slacker\"/><meta name=\"sailthru.description\" content=\"Americans aren’t getting the new bivalent COVID shot. What does that mean for the looming winter wave?\"/><meta name=\"sailthru.tags\" content=\"health,author-yasmin-tayag\"/><meta name=\"sailthru.date\" content=\"2022-10-25T18:27:00Z\"/><link rel=\"preload\" as=\"font\" type=\"font/woff2\" href=\"https://www.theatlantic.com/packages/fonts/garamond/AGaramondPro-Regular.woff2\" crossorigin=\"\"/><link rel=\"preload\" as=\"font\" type=\"font/woff2\" href=\"https://www.theatlantic.com/packages/fonts/graphik/Graphik-Regular-Web.woff2\" crossorigin=\"\"/><link rel=\"preload\" as=\"font\" type=\"font/woff2\" href=\"https://www.theatlantic.com/packages/fonts/graphik/Graphik-Semibold-Web.woff2\" crossorigin=\"\"/><link rel=\"preload\" as=\"font\" type=\"font/woff2\" href=\"https://www.theatlantic.com/packages/fonts/logic/LogicMonospace-Medium.woff2\" crossorigin=\"\"/><link rel=\"preload\" as=\"font\" type=\"font/woff2\" href=\"https://www.theatlantic.com/packages/fonts/logic/LogicMonospace-Regular.woff2\" crossorigin=\"\"/><script type=\"application/ld+json\">{\"@context\":\"https://schema.org\",\"@type\":\"NewsArticle\",\"headline\":\"America’s COVID-Booster Rates Are a Bad Sign for Winter\",\"alternativeHeadline\":\"It’s a Bad Time to Be a Booster Slacker\",\"description\":\"Americans aren’t getting the new bivalent COVID shot. What does that mean for the looming winter wave?\",\"url\":\"https://www.theatlantic.com/health/archive/2022/10/americas-covid-booster-rates-are-a-bad-sign-for-winter/671860/\",\"datePublished\":\"2022-10-25T18:27:00Z\",\"dateModified\":\"2022-10-26T11:26:26Z\",\"isAccessibleForFree\":false,\"hasPart\":{\"@type\":\"WebPageElement\",\"isAccessibleForFree\":false,\"cssSelector\":\".article-content-body\"},\"publisher\":{\"@id\":\"https://www.theatlantic.com/#publisher\"},\"mainEntityOfPage\":{\"@type\":\"WebPage\",\"@id\":\"https://www.theatlantic.com/health/archive/2022/10/americas-covid-booster-rates-are-a-bad-sign-for-winter/671860/\"},\"image\":[{\"@type\":\"ImageObject\",\"width\":{\"@type\":\"QuantitativeValue\",\"unitCode\":\"E37\",\"value\":720},\"height\":{\"@type\":\"QuantitativeValue\",\"unitCode\":\"E37\",\"value\":405},\"url\":\"https://cdn.theatlantic.com/thumbor/vP84RqWMxb91TvQRl76ShrQBfA8=/0x0:3997x2248/720x405/media/img/mt/2022/10/original-5/original.jpg\"},{\"@type\":\"ImageObject\",\"width\":{\"@type\":\"QuantitativeValue\",\"unitCode\":\"E37\",\"value\":1080},\"height\":{\"@type\":\"QuantitativeValue\",\"unitCode\":\"E37\",\"value\":1080},\"url\":\"https://cdn.theatlantic.com/thumbor/uVy5eRV4IxN__6jt6-rjkyrr284=/1227x0:3929x2702/1080x1080/media/img/mt/2022/10/original-5/original.jpg\"},{\"@type\":\"ImageObject\",\"width\":{\"@type\":\"QuantitativeValue\",\"unitCode\":\"E37\",\"value\":1200},\"height\":{\"@type\":\"QuantitativeValue\",\"unitCode\":\"E37\",\"value\":900},\"url\":\"https://cdn.theatlantic.com/thumbor/cWxDBLbrkpiEMpvggikcFZ3L3Rk=/267x0:3734x2600/1200x900/media/img/mt/2022/10/original-5/original.jpg\"},{\"@type\":\"ImageObject\",\"width\":{\"@type\":\"QuantitativeValue\",\"unitCode\":\"E37\",\"value\":1600},\"height\":{\"@type\":\"QuantitativeValue\",\"unitCode\":\"E37\",\"value\":900},\"url\":\"https://cdn.theatlantic.com/thumbor/CveTyp4MDHY45mxtokXiwEeck1Y=/0x0:3997x2248/1600x900/media/img/mt/2022/10/original-5/original.jpg\"},{\"@type\":\"ImageObject\",\"width\":{\"@type\":\"QuantitativeValue\",\"unitCode\":\"E37\",\"value\":960},\"height\":{\"@type\":\"QuantitativeValue\",\"unitCode\":\"E37\",\"value\":540},\"url\":\"https://cdn.theatlantic.com/thumbor/v0GNZffQTN6fPf-jrigYoEaENJ8=/0x0:3997x2248/960x540/media/img/mt/2022/10/original-5/original.jpg\"},{\"@type\":\"ImageObject\",\"width\":{\"@type\":\"QuantitativeValue\",\"unitCode\":\"E37\",\"value\":540},\"height\":{\"@type\":\"QuantitativeValue\",\"unitCode\":\"E37\",\"value\":540},\"url\":\"https://cdn.theatlantic.com/thumbor/UKlL8Q9bfCzkrFh3kFhR8SNDINg=/1227x0:3929x2702/540x540/media/img/mt/2022/10/original-5/original.jpg\"}],\"author\":[{\"@type\":\"Person\",\"name\":\"Yasmin Tayag\",\"sameAs\":\"https://www.theatlantic.com/author/yasmin-tayag/\"}],\"articleSection\":\"Health\"}</script><link rel=\"preload\" as=\"image\" href=\"https://cdn.theatlantic.com/thumbor/v0GNZffQTN6fPf-jrigYoEaENJ8=/0x0:3997x2248/960x540/media/img/mt/2022/10/original-5/original.jpg\" imageSrcSet=\"https://cdn.theatlantic.com/thumbor/ypadUpmVZasWiH0UK19UIWCk-DY=/0x0:3997x2248/750x422/media/img/mt/2022/10/original-5/original.jpg 750w, https://cdn.theatlantic.com/thumbor/UjW1EycehV4idraMjXXTUzdzM3Y=/0x0:3997x2248/828x466/media/img/mt/2022/10/original-5/original.jpg 828w, https://cdn.theatlantic.com/thumbor/v0GNZffQTN6fPf-jrigYoEaENJ8=/0x0:3997x2248/960x540/media/img/mt/2022/10/original-5/original.jpg 960w, https://cdn.theatlantic.com/thumbor/_VN9lLez7t_KGDXf5AFrwYIjXH0=/0x0:3997x2248/976x549/media/img/mt/2022/10/original-5/original.jpg 976w, https://cdn.theatlantic.com/thumbor/iRjqgy5ntF48AWXHpMjk2PCkLuM=/0x0:3997x2248/1952x1098/media/img/mt/2022/10/original-5/original.jpg 1952w\" imageSizes=\"(min-width: 976px) 976px, 100vw\"/><meta name=\"next-head-count\" content=\"64\"/><link rel=\"preload\" href=\"https://cdn.theatlantic.com/_next/static/css/b95b4320f6718b0c.css\" as=\"style\"/><link rel=\"stylesheet\" href=\"https://cdn.theatlantic.com/_next/static/css/b95b4320f6718b0c.css\" data-n-g=\"\"/><link rel=\"preload\" href=\"https://cdn.theatlantic.com/_next/static/css/83dd37c43a5ca464.css\" as=\"style\"/><link rel=\"stylesheet\" href=\"https://cdn.theatlantic.com/_next/static/css/83dd37c43a5ca464.css\" data-n-p=\"\"/><link rel=\"preload\" href=\"https://cdn.theatlantic.com/_next/static/css/86134947d37d3042.css\" as=\"style\"/><link rel=\"stylesheet\" href=\"https://cdn.theatlantic.com/_next/static/css/86134947d37d3042.css\" data-n-p=\"\"/><link rel=\"preload\" href=\"https://cdn.theatlantic.com/_next/static/css/e7e581efc0204d94.css\" as=\"style\"/><link rel=\"stylesheet\" href=\"https://cdn.theatlantic.com/_next/static/css/e7e581efc0204d94.css\" data-n-p=\"\"/><link rel=\"preload\" href=\"https://cdn.theatlantic.com/_next/static/css/affdcb0119874ec9.css\" as=\"style\"/><link rel=\"stylesheet\" href=\"https://cdn.theatlantic.com/_next/static/css/affdcb0119874ec9.css\" data-n-p=\"\"/><link rel=\"preload\" href=\"https://cdn.theatlantic.com/_next/static/css/46047a12f0663966.css\" as=\"style\"/><link rel=\"stylesheet\" href=\"https://cdn.theatlantic.com/_next/static/css/46047a12f0663966.css\"/><link rel=\"preload\" href=\"https://cdn.theatlantic.com/_next/static/css/c6d1bfe0dd65d735.css\" as=\"style\"/><link rel=\"stylesheet\" href=\"https://cdn.theatlantic.com/_next/static/css/c6d1bfe0dd65d735.css\"/><noscript data-n-css=\"\"></noscript><link rel=\"preload\" href=\"https://cdn.theatlantic.com/_next/static/chunks/6449.64aa63d8dc3c0934.js\" as=\"script\"/><link rel=\"preload\" href=\"https://cdn.theatlantic.com/_next/static/chunks/2839.28ced1947611cbe2.js\" as=\"script\"/><link rel=\"preload\" href=\"https://cdn.theatlantic.com/_next/static/chunks/webpack-4e2a44befefca0f2.js\" as=\"script\"/><link rel=\"preload\" href=\"https://cdn.theatlantic.com/_next/static/chunks/framework-2114f3935436c3d0.js\" as=\"script\"/><link rel=\"preload\" href=\"https://cdn.theatlantic.com/_next/static/chunks/main-1eeac463cdc5af3a.js\" as=\"script\"/><link rel=\"preload\" href=\"https://cdn.theatlantic.com/_next/static/chunks/pages/_app-0c4cdb774f4267b1.js\" as=\"script\"/><link rel=\"preload\" href=\"https://cdn.theatlantic.com/_next/static/chunks/6729-85e40cec85603df8.js\" as=\"script\"/><link rel=\"preload\" href=\"https://cdn.theatlantic.com/_next/static/chunks/5303-aee0b269eb8bb8f8.js\" as=\"script\"/><link rel=\"preload\" href=\"https://cdn.theatlantic.com/_next/static/chunks/2746-64955f9340e528e6.js\" as=\"script\"/><link rel=\"preload\" href=\"https://cdn.theatlantic.com/_next/static/chunks/1902-8f8938b0370f1477.js\" as=\"script\"/><link rel=\"preload\" href=\"https://cdn.theatlantic.com/_next/static/chunks/2739-71109d77017fa907.js\" as=\"script\"/><link rel=\"preload\" href=\"https://cdn.theatlantic.com/_next/static/chunks/3634-14d031932913845a.js\" as=\"script\"/><link rel=\"preload\" href=\"https://cdn.theatlantic.com/_next/static/chunks/9712-ed128833df024aa9.js\" as=\"script\"/><link rel=\"preload\" href=\"https://cdn.theatlantic.com/_next/static/chunks/4634-85677810286a9f26.js\" as=\"script\"/><link rel=\"preload\" href=\"https://cdn.theatlantic.com/_next/static/chunks/6759-ec3b029465507e70.js\" as=\"script\"/><link rel=\"preload\" href=\"https://cdn.theatlantic.com/_next/static/chunks/4348-d7f32ff2e6db85e4.js\" as=\"script\"/><link rel=\"preload\" href=\"https://cdn.theatlantic.com/_next/static/chunks/5145-8410897236b0d0f4.js\" as=\"script\"/><link rel=\"preload\" href=\"https://cdn.theatlantic.com/_next/static/chunks/7455-cf562e1d1a46e22a.js\" as=\"script\"/><link rel=\"preload\" href=\"https://cdn.theatlantic.com/_next/static/chunks/7124-2a8540ed513c75a5.js\" as=\"script\"/><link rel=\"preload\" href=\"https://cdn.theatlantic.com/_next/static/chunks/393-e6ccecd668f397ae.js\" as=\"script\"/><link rel=\"preload\" href=\"https://cdn.theatlantic.com/_next/static/chunks/pages/%5Bchannel%5D/archive/%5Byear%5D/%5Bmonth%5D/%5Bslug%5D/%5Bid%5D-ace40525ba90f8db.js\" as=\"script\"/></head><body><div id=\"__next\"><div data-category=\"story page\" data-event-surface=\"article\"><div></div><nav class=\"Nav_root__HcZek\" aria-labelledby=\"site-navigation\" data-category=\"Site Nav\" data-event-module=\"site nav\" id=\"main-navigation\"><div class=\"Nav_mainNav__iPsWc\"><a href=\"#main-content\" class=\"Nav_skipLink__P4Y5R\">Skip to content</a><h2 id=\"site-navigation\" class=\"Nav_visuallyHide__Lzzui\">Site Navigation</h2><div class=\"Nav_flexContainer__9iJ4H\"><ul class=\"Nav_leftContainer__Xs54R\"><li class=\"Nav_navListItem__l2afO Nav_visuallyHideOnMobile__N9bs2\"><a href=\"/\" class=\"Nav_navLink__34Bol\"><svg xmlns=\"http://www.w3.org/2000/svg\" viewBox=\"0 0 87.83 134\" class=\"Nav_bigA__c1aIb\"><title>The Atlantic</title><path d=\"M24.48 95.13c-.56 0-.74-.37-.74-.93l13.08-55.88c.19-.94.93-.94 1.12 0L50.09 94.2c0 .56-.19.93-.75.93zM48.22.19a22.54 22.54 0 01-7.66 5.05c-.75.19-.94.37-1.13 1.12l-26.72 112.5c-2 9-4.67 10.66-11.77 11.22a.88.88 0 00-.94.93v2.06a.88.88 0 00.92.93h25.6a.88.88 0 00.93-.93V131a.88.88 0 00-.93-.93c-9.53 0-10.47-2.81-8.6-10.66l4.49-19.25a1.18 1.18 0 011.12-.93h26.74a1.19 1.19 0 011.13.93l5 23.18c1.12 5-.75 6.17-7.1 6.73a.88.88 0 00-.93.93v2.06a.88.88 0 00.93.93h37.62a.88.88 0 00.94-.93V131a.88.88 0 00-.94-.93c-5.79-.56-8.22-1.5-9.34-6.73L49.34.57c-.19-.56-.75-.75-1.12-.38\"></path></svg></a></li><li class=\"Nav_navListItem__l2afO Nav_hamburgerLi__gP6Dn\"><button class=\"NavHamburgerButton_root__OgJkB\" aria-expanded=\"false\" aria-controls=\"expanded-nav\" aria-label=\"Open Main Menu\" data-action=\"Open Menu\"><div class=\"NavHamburgerButton_burger__jIWmI\"><div class=\"NavHamburgerButton_box__J5rDn\"><div class=\"NavHamburgerButton_inner__dKlIy\"></div></div></div></button><div class=\"Nav_expandedNav__o5Zj_\"><div hidden=\"\" class=\"ExpandedNav_root__r3hKE\" id=\"expanded-nav\"><div class=\"ExpandedNav_mobileHeader__QEenD\" data-event-element=\"mobile links\"><button class=\"ExpandedNav_searchButton__85mWm\" aria-label=\"Search The Atlantic\" data-action=\"open search\"><svg xmlns=\"http://www.w3.org/2000/svg\" viewBox=\"0 0 16 16\" class=\"ExpandedNav_searchIcon__2EngD\"><path d=\"M15.85 15.15l-5.27-5.28a6 6 0 10-.71.71l5.28 5.27a.48.48 0 00.7 0 .48.48 0 000-.7zM1 6a5 5 0 115 5 5 5 0 01-5-5z\"></path></svg></button><div><a class=\"ExpandedNav_mostPopular__EbSyn\" href=\"/most-popular/\" data-action=\"expanded\">Popular</a><a class=\"ExpandedNav_latest__zSrBe\" href=\"/latest/\" data-action=\"expanded\">Latest</a><a class=\"ExpandedNav_newsletters__W83ni\" href=\"/newsletters/\" data-action=\"expanded\">Newsletters</a></div></div><div class=\"ExpandedNav_container__sDhOz\"><div class=\"ExpandedNav_sections__oGeXo\" data-event-element=\"sections\"><h2 class=\"ExpandedNav_title__C8QcN ExpandedNav_sectionTitle___xWBI\">Sections</h2><ul class=\"ExpandedNav_sectionUl__mLUY1\"><li class=\"ExpandedNav_sectionLi__tZz7K\"><a href=\"/politics/\" data-action=\"expanded\" class=\"ExpandedNav_sectionLink__3iXo9\">Politics</a></li><li class=\"ExpandedNav_sectionLi__tZz7K\"><a href=\"/ideas/\" data-action=\"expanded\" class=\"ExpandedNav_sectionLink__3iXo9\">Ideas</a></li><li class=\"ExpandedNav_sectionLi__tZz7K\"><a href=\"https://www.theatlantic.com/category/fiction/\" data-action=\"expanded\" class=\"ExpandedNav_sectionLink__3iXo9\">Fiction</a></li><li class=\"ExpandedNav_sectionLi__tZz7K\"><a href=\"/technology/\" data-action=\"expanded\" class=\"ExpandedNav_sectionLink__3iXo9\">Technology</a></li><li class=\"ExpandedNav_sectionLi__tZz7K\"><a href=\"/science/\" data-action=\"expanded\" class=\"ExpandedNav_sectionLink__3iXo9\">Science</a></li><li class=\"ExpandedNav_sectionLi__tZz7K\"><a href=\"https://www.theatlantic.com/photo/\" data-action=\"expanded\" class=\"ExpandedNav_sectionLink__3iXo9\">Photo</a></li><li class=\"ExpandedNav_sectionLi__tZz7K\"><a href=\"/business/\" data-action=\"expanded\" class=\"ExpandedNav_sectionLink__3iXo9\">Business</a></li><li class=\"ExpandedNav_sectionLi__tZz7K\"><a href=\"/culture/\" data-action=\"expanded\" class=\"ExpandedNav_sectionLink__3iXo9\">Culture</a></li><li class=\"ExpandedNav_sectionLi__tZz7K\"><a href=\"/projects/planet/\" data-action=\"expanded\" class=\"ExpandedNav_sectionLink__3iXo9\">Planet</a></li><li class=\"ExpandedNav_sectionLi__tZz7K\"><a href=\"/international/\" data-action=\"expanded\" class=\"ExpandedNav_sectionLink__3iXo9\">Global</a></li><li class=\"ExpandedNav_sectionLi__tZz7K\"><a href=\"/books/\" data-action=\"expanded\" class=\"ExpandedNav_sectionLink__3iXo9\">Books</a></li><li class=\"ExpandedNav_sectionLi__tZz7K\"><a href=\"/audio/\" data-action=\"expanded\" class=\"ExpandedNav_sectionLink__3iXo9\">Audio</a></li><li class=\"ExpandedNav_sectionLi__tZz7K\"><a href=\"/health/\" data-action=\"expanded\" class=\"ExpandedNav_sectionLink__3iXo9\">Health</a></li><li class=\"ExpandedNav_sectionLi__tZz7K\"><a href=\"/education/\" data-action=\"expanded\" class=\"ExpandedNav_sectionLink__3iXo9\">Education</a></li><li class=\"ExpandedNav_sectionLi__tZz7K\"><a href=\"/projects/\" data-action=\"expanded\" class=\"ExpandedNav_sectionLink__3iXo9\">Projects</a></li><li class=\"ExpandedNav_sectionLi__tZz7K\"><a href=\"https://www.theatlantic.com/category/features/\" data-action=\"expanded\" class=\"ExpandedNav_sectionLink__3iXo9\">Features</a></li><li class=\"ExpandedNav_sectionLi__tZz7K\"><a href=\"/family/\" data-action=\"expanded\" class=\"ExpandedNav_sectionLink__3iXo9\">Family</a></li><li class=\"ExpandedNav_sectionLi__tZz7K\"><a href=\"/events/\" data-action=\"expanded\" class=\"ExpandedNav_sectionLink__3iXo9\">Events</a></li><li class=\"ExpandedNav_sectionLi__tZz7K\"><a href=\"https://www.theatlantic.com/category/washington-week-atlantic/\" data-action=\"expanded\" class=\"ExpandedNav_sectionLink__3iXo9\">Washington Week</a></li><li class=\"ExpandedNav_sectionLi__tZz7K\"><a href=\"https://www.theatlantic.com/progress/\" data-action=\"expanded\" class=\"ExpandedNav_sectionLink__3iXo9\">Progress</a></li><li class=\"ExpandedNav_sectionLi__tZz7K\"><a href=\"/newsletters/\" data-action=\"expanded\" class=\"ExpandedNav_sectionLink__3iXo9\">Newsletters</a></li></ul></div><div class=\"ExpandedNav_moreLinks__G4VPb\" data-event-element=\"more links\"><ul class=\"ExpandedNav_moreLinksList__u0bVY\"><li class=\"ExpandedNav_moreLinksListItem__UrTkv\"><a href=\"/archive/\" class=\"ExpandedNav_moreLinksItem__JhFzM\" data-action=\"archive\"><img alt=\"\" loading=\"lazy\" class=\"Image_root__XxsOp Image_lazy__hYWHV ExpandedNav_moreLinksImg__IY3fl\" src=\"https://cdn.theatlantic.com/_next/static/images/nav-archive-promo-5541b02ae92f1a9276249e1c6c2534ee.png\" width=\"80\" height=\"80\"/><span>Explore The Atlantic Archive</span></a></li><li class=\"ExpandedNav_moreLinksListItem__UrTkv\"><a href=\"/free-daily-crossword-puzzle/\" class=\"ExpandedNav_moreLinksItem__JhFzM\" data-action=\"crossword\"><svg width=\"80\" height=\"80\" viewBox=\"0 0 64 64\" fill=\"none\" xmlns=\"http://www.w3.org/2000/svg\" class=\"ExpandedNav_moreLinksImg__IY3fl\"><g clip-path=\"url(#crossword-promo_svg__clip0_1939_66324)\"><path fill=\"#E7131A\" d=\"M0 0h64v64H0z\"></path><path d=\"M37.988 26.531H26.516v11.474h11.472V26.53zM37.988 38.805H26.516V50.28h11.472V38.805zM25.715 26.531H14.243v11.474h11.472V26.53zM50.26 26.531H38.789v11.474h11.473V26.53zM36.469 16.842c.096.183.156.39.156.612a1.326 1.326 0 11-1.326-1.327c.197 0 .384.047.552.124.167-.464.303-1.137.338-1.993h-5.287c-.039.968-.217 1.908-.527 2.584.096.183.156.39.156.612a1.326 1.326 0 11-1.327-1.327c.198 0 .384.047.552.124.167-.464.303-1.137.339-1.993h-3.58v11.474h11.472V14.258h-.992c-.038.968-.216 1.908-.526 2.584z\" fill=\"#fff\"></path><path d=\"M47.487 17.853a.4.4 0 010-.8c.135 0 .36-.27.552-.803a1.313 1.313 0 00-.552-.124 1.326 1.326 0 101.326 1.327c0-.222-.06-.428-.156-.612-.282.615-.674 1.012-1.17 1.012zM41.393 17.853a.4.4 0 010-.8c.135 0 .36-.27.552-.803a1.313 1.313 0 00-.552-.124 1.326 1.326 0 101.326 1.327c0-.222-.06-.428-.156-.612-.282.615-.673 1.012-1.17 1.012zM35.298 17.853a.4.4 0 010-.8c.135 0 .36-.27.552-.803a1.313 1.313 0 00-.552-.124 1.326 1.326 0 101.326 1.327c0-.222-.06-.428-.156-.612-.282.615-.673 1.012-1.17 1.012zM29.204 17.853a.4.4 0 010-.8c.136 0 .36-.27.552-.803a1.313 1.313 0 00-.552-.124 1.326 1.326 0 101.327 1.327c0-.222-.06-.428-.156-.612-.282.615-.673 1.012-1.17 1.012zM23.11 17.853a.4.4 0 010-.8c.135 0 .36-.27.552-.803a1.313 1.313 0 00-.552-.124 1.326 1.326 0 101.326 1.327c0-.222-.06-.428-.156-.612-.282.615-.673 1.012-1.17 1.012zM17.016 17.853a.4.4 0 010-.8c.135 0 .36-.27.552-.803a1.313 1.313 0 00-.552-.124 1.326 1.326 0 101.326 1.327c0-.222-.06-.428-.156-.612-.282.615-.672 1.012-1.17 1.012z\" fill=\"#E7131A\"></path><path d=\"M50.66 13.458h-1.476c-.072-1.85-.652-3.605-1.698-3.605-1.045 0-1.624 1.753-1.697 3.605h-2.7c-.071-1.85-.651-3.605-1.698-3.605-1.045 0-1.624 1.753-1.697 3.605h-2.7c-.072-1.85-.652-3.605-1.698-3.605-1.045 0-1.624 1.753-1.697 3.605H30.9c-.072-1.85-.652-3.605-1.698-3.605-1.045 0-1.624 1.753-1.697 3.605h-2.697c-.072-1.85-.652-3.605-1.698-3.605-1.045 0-1.624 1.753-1.697 3.605h-2.7c-.071-1.85-.651-3.605-1.698-3.605-1.045 0-1.624 1.753-1.697 3.605h-1.476a.4.4 0 00-.4.4V50.68c0 .22.18.4.4.4H50.66a.4.4 0 00.4-.4V13.858c0-.221-.178-.4-.4-.4zm-20.565.8c-.035.855-.171 1.528-.338 1.992-.192.532-.417.803-.552.803a.4.4 0 000 .8c.497 0 .888-.398 1.17-1.012.31-.676.488-1.616.527-2.583h5.288c-.036.855-.172 1.528-.339 1.992-.192.532-.417.803-.552.803a.4.4 0 000 .8c.498 0 .888-.398 1.17-1.012.311-.676.489-1.616.528-2.583h.992V25.73H26.515V14.258h3.58zm20.166 23.747H38.788V26.53h11.473v11.474zM14.243 26.53h11.472v11.474H14.243V26.53zm34.57-9.078a1.326 1.326 0 11-1.327-1.327c.198 0 .384.047.552.124-.192.532-.416.803-.552.803a.4.4 0 000 .8c.498 0 .888-.398 1.17-1.012.097.184.157.39.157.612zm-7.42.4c.497 0 .888-.398 1.17-1.012.096.183.156.39.156.612a1.326 1.326 0 11-1.326-1.327c.197 0 .384.047.552.124-.192.532-.417.803-.552.803a.4.4 0 000 .8zm-3.405 20.152H26.515V26.53h11.473v11.474zM24.436 17.453a1.326 1.326 0 11-1.326-1.327c.197 0 .384.047.552.124-.192.532-.417.803-.552.803a.4.4 0 000 .8c.497 0 .888-.398 1.17-1.012.097.184.156.39.156.612zm-6.094 0a1.326 1.326 0 11-1.326-1.327c.198 0 .384.047.552.124-.192.532-.417.803-.552.803a.4.4 0 000 .8c.498 0 .888-.398 1.17-1.012.097.184.156.39.156.612zm8.173 21.352h11.473V50.28H26.515V38.805zm20.971-28.152c.253 0 .817.96.892 2.805h-1.782c.075-1.844.638-2.805.89-2.805zm-6.093 0c.253 0 .817.96.891 2.805h-1.782c.076-1.844.638-2.805.89-2.805zm-6.095 0c.253 0 .817.96.892 2.805h-1.782c.075-1.844.638-2.805.89-2.805zm-6.094 0c.253 0 .817.96.891 2.805h-1.781c.075-1.844.637-2.805.89-2.805zm-6.094 0c.252 0 .816.96.89 2.805h-1.78c.074-1.844.637-2.805.89-2.805zm-6.094 0c.253 0 .817.96.891 2.805h-1.781c.075-1.844.637-2.805.89-2.805z\" fill=\"#000\"></path></g><defs><clipPath id=\"crossword-promo_svg__clip0_1939_66324\"><path fill=\"#fff\" d=\"M0 0h64v64H0z\"></path></clipPath></defs></svg><span>Play The Atlantic crossword</span></a></li><li class=\"ExpandedNav_moreLinksListItem__UrTkv\"><a href=\"/audio/\" class=\"ExpandedNav_moreLinksItem__JhFzM\" data-action=\"audio\"><svg width=\"80\" height=\"80\" viewBox=\"0 0 64 64\" fill=\"none\" xmlns=\"http://www.w3.org/2000/svg\" class=\"ExpandedNav_moreLinksImg__IY3fl\"><path fill=\"#FAF4EB\" d=\"M0 0h63.998v64H0z\"></path><path d=\"M25.267 31.27h-1.171v12.138h1.17a.392.392 0 00.393-.392V31.662a.392.392 0 00-.392-.393v.002zM38.34 31.662v11.354c0 .217.175.392.392.392h1.171V31.271h-1.17a.392.392 0 00-.393.392v-.002z\" fill=\"#000\"></path><path d=\"M44.605 33.479c.106-.69.163-1.398.163-2.12 0-7.343-5.718-13.296-12.77-13.296-7.05 0-12.768 5.953-12.768 13.296 0 .722.057 1.429.163 2.12l-1.413.58v6.56l2.033.834a3.194 3.194 0 001.586 1.65c.411.193.869.305 1.353.305h.34V31.271h-.34c-.174 0-.345.017-.511.044a3.14 3.14 0 00-1.236.48c-.005-.145-.011-.289-.011-.434 0-6.25 4.847-11.334 10.805-11.334 5.958 0 10.805 5.085 10.805 11.334 0 .145-.005.29-.01.433a3.163 3.163 0 00-1.748-.523h-.34v12.137h.34a3.197 3.197 0 002.939-1.953l2.033-.835v-6.56l-1.413-.58v-.001zM35.71 49.806a.498.498 0 100 .997.498.498 0 000-.997zM30.235 50.8a.498.498 0 100-.996.498.498 0 000 .997zM28.059 48.218a.498.498 0 100 .997.498.498 0 000-.997zM32.104 50.072a.498.498 0 100-.997.498.498 0 000 .997zM33.105 47.731a.498.498 0 100 .997.498.498 0 000-.997zM29.675 48.09a.498.498 0 10.996 0 .498.498 0 00-.996 0zM35.71 48.156a.498.498 0 10-.997 0 .498.498 0 00.997 0zM37.508 49.085a.498.498 0 100 .996.498.498 0 000-.996zM39 47.336a.498.498 0 100 .996.498.498 0 000-.996zM39.159 45.754a.498.498 0 100 .996.498.498 0 000-.996zM40.74 46.07a.498.498 0 100 .997.498.498 0 000-.997zM40.266 44.33a.498.498 0 100 .997.498.498 0 000-.997zM34.47 49.983a.498.498 0 10-.996 0 .498.498 0 00.997 0zM27.746 51.075a.498.498 0 100-.997.498.498 0 000 .997zM29.736 51.668a.498.498 0 100 .996.498.498 0 000-.996zM32.375 52.8a.498.498 0 100-.997.498.498 0 000 .997zM48.894 42.2a.498.498 0 100 .997.498.498 0 000-.997zM50.794 25.623a.497.497 0 10.7.082.497.497 0 00-.7-.082zM50.32 27.679a.497.497 0 10.7.082.497.497 0 00-.7-.082zM48.52 25.229a.497.497 0 10.78-.614.497.497 0 00-.78.614zM48.809 20.633a.498.498 0 10.616.781.498.498 0 00-.616-.781zM52.468 24.48a.497.497 0 10.78-.614.497.497 0 00-.78.615zM54.84 24.769a.498.498 0 10.617.781.498.498 0 00-.616-.781zM55.338 27.141a.497.497 0 10.782-.617.497.497 0 10-.782.617zM53.817 27.018a.497.497 0 10-.781.614.497.497 0 00.781-.614zM57.145 29.216a.498.498 0 10-.616-.781.498.498 0 00.616.781zM55.064 23.779a.498.498 0 10-.617-.782.498.498 0 00.617.782zM40.054 13.142a.498.498 0 10-.617-.781.498.498 0 00.617.781zM53.735 21.578a.498.498 0 10-.616-.78.498.498 0 00.616.78zM55.85 31.981a.497.497 0 10-.78.614.497.497 0 00.78-.614zM54.84 33.58a.498.498 0 10.617.781.498.498 0 00-.616-.78zM56.316 35.18a.497.497 0 10.617.784.497.497 0 00-.617-.783zM55.966 37.762a.498.498 0 10.616.781.498.498 0 00-.616-.781zM56.498 33.18a.498.498 0 10.617.781.498.498 0 00-.617-.781zM53.13 41.909a.498.498 0 10.617.78.498.498 0 00-.617-.78zM42.078 49.183a.498.498 0 10.617.781.498.498 0 00-.617-.781zM40.255 50.41a.498.498 0 10.616.782.498.498 0 00-.616-.782zM36.42 51.49a.498.498 0 10.618.782.498.498 0 00-.617-.782zM33.851 51.728a.498.498 0 10.617.78.498.498 0 00-.617-.78zM38.312 50.842a.498.498 0 10.616.781.498.498 0 00-.616-.78zM50.653 43.918a.498.498 0 10-.617-.78.498.498 0 00.617.78zM50.393 44.936a.498.498 0 10.616.782.498.498 0 00-.616-.782zM57.489 31.298a.497.497 0 10-.782.617.497.497 0 10.782-.617zM51.652 19.689a.497.497 0 10-.617-.784.497.497 0 00.617.784zM51.154 21.688a.498.498 0 10-.616-.782.498.498 0 00.616.782zM48.69 19.641a.497.497 0 10.781-.614.497.497 0 00-.781.614zM48.465 17.63a.498.498 0 10-.617-.782.498.498 0 00.617.781zM46.498 16.596a.5.5 0 00.554-.435.5.5 0 00-.99-.118.5.5 0 00.436.553zM46.244 18.243a.5.5 0 00.435.554.5.5 0 00.554-.436.5.5 0 00-.435-.553.5.5 0 00-.554.435zM45.325 15.307a.5.5 0 00.554-.435.5.5 0 00-.989-.118.5.5 0 00.435.553zM42.096 13.917a.5.5 0 00.554-.435.5.5 0 00-.435-.553.5.5 0 00-.554.434.5.5 0 00.435.554zM49.606 18.61a.5.5 0 00.554-.435.5.5 0 00-.989-.119.5.5 0 00.435.554zM45.478 17.63a.498.498 0 10-.616-.782.498.498 0 00.616.781zM43.392 17.311a.497.497 0 10-.782.617.497.497 0 10.782-.617zM54.34 36.596a.498.498 0 10.781-.618.498.498 0 00-.782.618zM53.384 36.69a.498.498 0 10-.617-.782.498.498 0 00.617.782zM51.95 37.01a.497.497 0 10-.7-.082c.172.217.483.253.7.083zM53.176 31.27a.498.498 0 10.616.782.498.498 0 00-.616-.781zM54.792 30.407a.498.498 0 10.616.782.498.498 0 00-.616-.782zM52.13 32.454a.498.498 0 10.617.781.498.498 0 00-.617-.781zM53.656 35.098a.498.498 0 10-.616-.781.498.498 0 00.616.781zM53.384 30.417a.498.498 0 10-.617-.782.498.498 0 00.617.782zM54.654 28.826a.498.498 0 10-.616-.782.498.498 0 00.616.782zM51.187 31.662a.497.497 0 10-.781.616.497.497 0 10.781-.616zM48.774 26.268a.497.497 0 10.7.082.497.497 0 00-.7-.082zM49.475 29.322a.498.498 0 10-.617-.781.498.498 0 00.617.781zM49.974 33.465a.498.498 0 10-.617-.782.498.498 0 00.617.782zM50.242 35.438a.498.498 0 10-.616-.78.498.498 0 00.616.78zM48.915 34.097a.497.497 0 10-.662.742.497.497 0 00.662-.742zM47.957 35.54a.497.497 0 10-.662.743.497.497 0 10.662-.743zM47.582 37.525a.497.497 0 10-.662.743.497.497 0 10.662-.743zM51.792 34.599a.498.498 0 10-.617-.782.498.498 0 00.617.782zM49.54 29.909a.498.498 0 10.617.781.498.498 0 00-.617-.781zM52.032 28.215a.498.498 0 10.617.78.498.498 0 00-.617-.78zM53.158 26.426a.497.497 0 10-.7-.082c.171.217.483.253.7.082zM48.578 32.179a.498.498 0 10-.617-.782.498.498 0 00.617.782zM50.89 30.403a.5.5 0 00.988.118.5.5 0 00-.989-.118zM46.624 25.265a.498.498 0 10.617.78.498.498 0 00-.617-.78z\" fill=\"#000\"></path><path d=\"M45.827 31.83a.497.497 0 10.7.082.497.497 0 00-.7-.083zM47.58 33.16a.497.497 0 10-.781.613.497.497 0 00.781-.614zM47.74 27.738a.498.498 0 10-.616-.782.498.498 0 00.616.782zM47.95 30.243a.5.5 0 00-.99-.119.5.5 0 00.99.119zM46.367 30.243a.5.5 0 00-.99-.119.5.5 0 00.99.119zM46.683 28.345a.5.5 0 00-.99-.119.5.5 0 00.99.119zM45.734 26.921a.5.5 0 00-.99-.118.5.5 0 00.99.118zM51.545 23.233a.497.497 0 10.781-.614.497.497 0 00-.781.614zM6.538 28.26a.499.499 0 10.51-.853.499.499 0 00-.51.852zM7.67 26.127a.499.499 0 10.51-.854.499.499 0 00-.51.854zM22.566 14.925a.499.499 0 10.51-.853.499.499 0 00-.51.853zM14.93 46.545a.499.499 0 10-.51.854.499.499 0 00.51-.854zM14.43 45.648a.499.499 0 10-.856-.512.499.499 0 00.856.512zM8.545 24.343a.499.499 0 10.51-.853.499.499 0 00-.51.853zM9.538 22.678a.5.5 0 10.51-.853.5.5 0 00-.51.853zM8.556 29.822a.499.499 0 10-.856-.512.499.499 0 00.856.512zM17.15 16.267a.498.498 0 10-.616-.781.498.498 0 00.616.781zM6.896 33.144a.498.498 0 10-.616-.782.498.498 0 00.616.782zM9.125 33.325a.498.498 0 10-.616-.781.498.498 0 00.616.781zM7.207 34.31a.498.498 0 10-.782.617.498.498 0 00.782-.618zM15.916 46.436a.498.498 0 100-.997.498.498 0 000 .997zM16.595 48.48a.498.498 0 100-.996.498.498 0 000 .997zM18.442 49.436a.498.498 0 100-.997.498.498 0 000 .997zM13.869 18.485a.498.498 0 100-.997.498.498 0 000 .997zM18.393 15.409a.498.498 0 100-.997.498.498 0 000 .997zM21.04 14.363a.497.497 0 10-.701-.704.497.497 0 00.702.704zM25.524 12.75a.497.497 0 10-.702-.704.497.497 0 00.702.704zM28.182 12.285a.497.497 0 10-.702-.704.497.497 0 00.702.704zM18.673 47.005a.498.498 0 10-.997 0 .498.498 0 00.997 0zM12.707 42.075a.498.498 0 10-.001.997.498.498 0 000-.997zM12.512 39.8a.498.498 0 10-.07-.993.498.498 0 00.07.994zM10.954 40.65a.498.498 0 100-.997.498.498 0 000 .997zM11.492 41.112a.498.498 0 100 .996.498.498 0 000-.996zM9.543 41.143a.498.498 0 100 .997.498.498 0 000-.997zM14.316 40.844a.498.498 0 10-.996 0 .498.498 0 00.996 0zM13.704 38.478a.498.498 0 100-.996.498.498 0 000 .996zM15.03 36.2a.498.498 0 10-.997 0 .498.498 0 00.997 0zM14.652 33.933a.498.498 0 100-.997.498.498 0 000 .997zM11.635 35.752a.498.498 0 100-.997.498.498 0 000 .997zM12.41 33.66a.498.498 0 100-.996.498.498 0 000 .997zM8.618 37.754a.498.498 0 10-.996 0 .498.498 0 00.996 0zM8.329 39.347a.498.498 0 100 .996.498.498 0 000-.996zM11.083 38.577a.498.498 0 10-.997 0 .498.498 0 00.997 0zM10.124 37.434a.498.498 0 100-.996.498.498 0 000 .996zM7.317 36.843a.498.498 0 100-.997.498.498 0 000 .997zM12.525 37.447a.497.497 0 10-.702-.704.497.497 0 00.702.704zM12.242 29.982a.498.498 0 100 .996.498.498 0 000-.996zM9.54 35.253a.498.498 0 10-.997 0 .498.498 0 00.997 0zM11.192 33.647a.498.498 0 10-.996 0 .498.498 0 00.996 0zM15.171 28.82a.498.498 0 100-.997.498.498 0 000 .996zM17.296 28.661a.498.498 0 100-.997.498.498 0 000 .997zM16.7 29.59a.498.498 0 10-.997 0 .498.498 0 00.996 0zM18.282 30.064a.498.498 0 10-.996 0 .498.498 0 00.996 0zM19.386 21.03a.498.498 0 100 .996.498.498 0 000-.996zM17.714 32.372a.498.498 0 100-.997.498.498 0 000 .997zM16.665 33.488a.498.498 0 100-.996.498.498 0 000 .996zM16.225 35.07a.498.498 0 100-.997.498.498 0 000 .997zM16.665 36.63a.498.498 0 100-.997.498.498 0 000 .996zM11.908 25.748a.498.498 0 100-.997.498.498 0 000 .997zM15.123 21.001a.498.498 0 100 .997.498.498 0 000-.997zM15.047 20.157a.498.498 0 100-.997.498.498 0 000 .997zM16.58 18.614a.498.498 0 100-.996.498.498 0 000 .997zM15.621 17.62a.498.498 0 10.001-.997.498.498 0 000 .997zM13.37 20.775a.498.498 0 100-.997.498.498 0 000 .997zM11.91 20.248a.498.498 0 10.001-.996.498.498 0 000 .996zM11.35 21.843a.498.498 0 100-.997.498.498 0 000 .997zM14.343 26.426a.498.498 0 100-.996.498.498 0 000 .996zM13.206 25.16a.498.498 0 100-.997.498.498 0 000 .996zM11.76 27.034a.498.498 0 10.997 0 .498.498 0 00-.996 0zM9.499 25.113a.498.498 0 10.997 0 .498.498 0 00-.997 0zM13.357 22.923a.498.498 0 10-.07-.994.498.498 0 00.07.994zM11.248 23.943a.498.498 0 100-.997.498.498 0 000 .997zM9.829 30.444a.498.498 0 100-.997.498.498 0 000 .997zM6.477 30.706a.498.498 0 100-.996.498.498 0 000 .996zM40.136 14a.5.5 0 10.857.513.5.5 0 00-.857-.512zM39.218 15.744a.499.499 0 10.51-.853.499.499 0 00-.51.853zM39.038 17.507a.499.499 0 10.51-.853.499.499 0 00-.51.853zM37.456 17.982a.499.499 0 10.51-.853.499.499 0 00-.51.853zM41.253 15.885a.499.499 0 10.51-.854.499.499 0 00-.51.854zM41.353 17.536a.499.499 0 10-.857-.512.499.499 0 00.857.512zM8.566 31.717a.498.498 0 100-.997.498.498 0 000 .997zM9.944 31.593a.498.498 0 10.997 0 .498.498 0 00-.997 0zM11.185 29.07a.498.498 0 10.996 0 .498.498 0 00-.996 0zM8.995 27.706a.498.498 0 100-.997.498.498 0 000 .997zM10.51 28.41a.498.498 0 100-.997.498.498 0 000 .997zM13.48 29.227a.498.498 0 10.001-.996.498.498 0 000 .996zM15.417 32.092a.498.498 0 100-.997.498.498 0 000 .997zM13.704 32.215a.498.498 0 100-.997.498.498 0 000 .997zM14.501 30.37a.498.498 0 100-.997.498.498 0 000 .996zM44.77 48.378a.498.498 0 00-.518.85.498.498 0 00.518-.85zM44.012 45.958a.499.499 0 00.517-.85.498.498 0 00-.517.85zM42.917 46.809a.498.498 0 10-.851-.517.498.498 0 00.851.517zM46.904 44.45a.498.498 0 10.516-.849.498.498 0 00-.517.85zM46.057 44.471a.498.498 0 10-.852-.516.498.498 0 00.852.516zM44.79 43.206a.498.498 0 10-.851-.517.498.498 0 00.851.517zM46.407 46.65a.498.498 0 10-.852-.516.498.498 0 00.852.517zM44.657 47.563a.498.498 0 10-.852-.516.498.498 0 00.852.516zM46.963 47.375a.498.498 0 00-.517.85.498.498 0 00.517-.85zM39.595 48.876a.498.498 0 00-.518.85.498.498 0 00.518-.85zM41.32 47.967a.498.498 0 00-.517.849.498.498 0 00.517-.85zM36.547 47.83a.498.498 0 10.851.517.498.498 0 00-.851-.516zM33.264 45.833a.498.498 0 100 .997.498.498 0 000-.997zM35.394 45.468a.498.498 0 10-.997 0 .498.498 0 00.997 0zM36.23 46.249a.498.498 0 10.852.517.498.498 0 00-.852-.517zM37.813 44.351a.498.498 0 10.852.517.498.498 0 00-.852-.517zM47.713 45.044a.498.498 0 00-.517.85.498.498 0 00.517-.85zM49.34 44.473a.499.499 0 00-.518.85.498.498 0 00.518-.85zM48.94 46.502a.498.498 0 10-.516.849.498.498 0 00.516-.849zM50.182 41.493a.498.498 0 10.347.933.498.498 0 00-.347-.933zM49.576 40.558a.498.498 0 10-.934.348.498.498 0 00.934-.348zM46.79 42.667a.498.498 0 10-.346-.933.498.498 0 00.347.933zM47.899 39.962a.498.498 0 10-.933.348.498.498 0 00.933-.348zM51.826 41.47a.497.497 0 10-.346-.932.497.497 0 00.346.933zM49.417 38.224a.498.498 0 10-.933.347.498.498 0 00.933-.347zM50.899 38.714a.498.498 0 10-.933.348.498.498 0 00.933-.348zM49.917 36.489a.498.498 0 10-.934.348.498.498 0 00.934-.348zM51.808 37.923a.498.498 0 10.347.933.498.498 0 00-.347-.933zM25.17 15.247a.498.498 0 100-.996.498.498 0 000 .996zM25.17 16.549a.498.498 0 10.998 0 .498.498 0 00-.997 0zM41.896 19.856a.498.498 0 10-.996 0 .498.498 0 00.996 0zM43.262 18.78a.498.498 0 100 .996.498.498 0 000-.997zM52.1 43.393a.498.498 0 10-.414.906.498.498 0 00.414-.906zM54.618 40.212a.496.496 0 00-.494.501.496.496 0 00.502.494.496.496 0 00.494-.502.496.496 0 00-.502-.493zM54.758 37.561a.496.496 0 00-.493.501.496.496 0 00.501.494.496.496 0 00.494-.502.496.496 0 00-.502-.493zM53.63 39.454a.496.496 0 00-.502-.493.497.497 0 10.502.494zM15.092 23.477a.498.498 0 10.347.932.498.498 0 00-.347-.932zM16.58 20.122a.498.498 0 10.996 0 .498.498 0 00-.997 0zM15.584 26.195a.498.498 0 10.997 0 .498.498 0 00-.997 0zM18.37 27.473a.498.498 0 100-.996.498.498 0 000 .996zM17.454 22.898a.498.498 0 100 .996.498.498 0 000-.996zM17.454 24.796a.498.498 0 100 .996.498.498 0 000-.996zM19.924 19.307a.498.498 0 100 .997.498.498 0 000-.997zM18.988 23.441a.498.498 0 10-.07-.994.498.498 0 00.07.994zM16.878 21.428a.498.498 0 100 .997.498.498 0 000-.997zM30.591 13.057a.497.497 0 10.346.932.497.497 0 00-.346-.932zM30.323 15.714a.498.498 0 10-.346-.933.498.498 0 00.346.933zM32.607 12.294a.498.498 0 100-.996.498.498 0 000 .996zM27.075 16.225a.498.498 0 10.933-.348.498.498 0 00-.933.348zM32.284 16.261a.498.498 0 10-.347-.933.498.498 0 00.347.933zM36.416 13.586a.499.499 0 10-.71-.699.499.499 0 00.71.7zM37.33 12.522a.499.499 0 10-.712-.7.499.499 0 00.712.7zM35.19 12.328a.499.499 0 10-.71-.7.499.499 0 00.71.7zM35.425 16.1a.499.499 0 10.697-.709.499.499 0 00-.697.709zM37.708 15.619a.499.499 0 10-.712-.7.499.499 0 00.712.7zM37.516 14.336a.499.499 0 10.697-.708.499.499 0 00-.697.708zM32.283 13.41a.499.499 0 10.711.7.499.499 0 00-.711-.7zM43.28 15.606a.499.499 0 10.71.7.499.499 0 00-.71-.7zM43.688 14.83a.499.499 0 10-.711-.7.499.499 0 00.71.7zM34.645 14.847a.499.499 0 10-.711-.699.499.499 0 00.711.7zM22.876 13.54a.499.499 0 10.51-.854.499.499 0 00-.51.855zM26.427 13.996a.499.499 0 10.51-.853.499.499 0 00-.51.853zM28.11 13.745a.499.499 0 10.857.511.499.499 0 00-.856-.511zM30.125 12.127a.499.499 0 10.51-.853.499.499 0 00-.51.853zM19.727 46.404a.498.498 0 10.139-.688.497.497 0 00-.14.69v-.002zM21.264 16.28a.498.498 0 10.584-.807.498.498 0 00-.584.807zM23.283 17.712a.497.497 0 10-.806-.584.497.497 0 00.806.584zM21.883 20.704a.497.497 0 10-.806-.584.497.497 0 00.806.584zM22.367 18.346a.498.498 0 10-.584.806.498.498 0 00.584-.806zM23.632 19.295a.498.498 0 10-.583.806.498.498 0 00.583-.806zM21.258 21.825a.498.498 0 10-.583.807.498.498 0 00.583-.807zM19.194 44.97a.498.498 0 10-.984-.156.498.498 0 00.984.155zM17.093 44.084a.498.498 0 10-.156.983.498.498 0 00.156-.983zM18.877 43.184a.498.498 0 10.156-.983.498.498 0 00-.156.983zM19.72 47.355a.498.498 0 10-.156.983.498.498 0 00.156-.983zM13.898 44.147a.498.498 0 10.156-.983.498.498 0 00-.156.983zM11.166 43.092a.498.498 0 10-.156.983.498.498 0 00.156-.983zM12.732 44.693a.497.497 0 10-.643.758.497.497 0 00.643-.758zM25.903 49.082a.498.498 0 10-.156.983.498.498 0 00.156-.983zM25.294 48.085a.497.497 0 10.983.156.497.497 0 00-.983-.156zM24.187 46.662a.498.498 0 10.983.155.498.498 0 00-.983-.155zM25.294 45.397a.498.498 0 10.983.155.498.498 0 00-.983-.155zM26.56 43.657a.498.498 0 10.983.155.498.498 0 00-.983-.155zM26.718 47.136a.498.498 0 10.983.156.498.498 0 00-.983-.156zM27.826 45.397a.498.498 0 10.983.155.498.498 0 00-.983-.155zM29.567 46.187a.497.497 0 10.982.156.497.497 0 00-.982-.156zM31.308 45.238a.498.498 0 10.983.156.498.498 0 00-.983-.156zM31.308 47.294a.498.498 0 10.983.156.498.498 0 00-.983-.156zM26.826 51.355a.498.498 0 10-.156.983.498.498 0 00.156-.983zM30.548 44.587a.498.498 0 10-.997 0 .498.498 0 00.997 0zM29.282 42.847a.498.498 0 10-.996 0 .498.498 0 00.996 0zM29.575 38.505a.498.498 0 100-.996.498.498 0 000 .996zM31.662 35.834a.498.498 0 10-.997 0 .498.498 0 00.997 0zM30.306 40.375a.498.498 0 100-.997.498.498 0 000 .997zM32.148 40.878a.498.498 0 10-.996 0 .498.498 0 00.996 0zM31.79 37.449a.498.498 0 100 .996.498.498 0 000-.996zM31.722 43.48a.498.498 0 100-.997.498.498 0 000 .997zM30.529 42.559a.498.498 0 100-.996.498.498 0 000 .996zM29.302 36.017a.498.498 0 100-.996.498.498 0 000 .996zM28.369 37.669a.498.498 0 10-.997 0 .498.498 0 00.997 0zM28.526 40.805a.498.498 0 100-.997.498.498 0 000 .997zM26.943 39.856a.498.498 0 100-.997.498.498 0 000 .997zM27.832 41.465a.497.497 0 10-.782.616.497.497 0 10.782-.617zM34.047 41.036a.498.498 0 10-.997 0 .498.498 0 00.997 0zM34.413 43.321a.498.498 0 100-.996.498.498 0 000 .996zM33.305 44.903a.498.498 0 100-.997.498.498 0 000 .997zM36.224 34.494a.498.498 0 10-.156.983.498.498 0 00.156-.983zM32.743 34.494a.498.498 0 10-.156.983.498.498 0 00.156-.983zM34.484 35.601a.498.498 0 10-.156.984.498.498 0 00.156-.984zM33.692 37.341a.498.498 0 10-.156.984.498.498 0 00.156-.984zM34.642 39.081a.498.498 0 10-.156.983.498.498 0 00.156-.983zM32.585 39.081a.498.498 0 10-.156.983.498.498 0 00.156-.983zM27.256 36.342a.498.498 0 10-.983-.156.498.498 0 00.983.156zM27.732 34.76a.498.498 0 10-.983-.156.498.498 0 00.983.156zM24.091 50.586a.497.497 0 10.2.974.497.497 0 00-.2-.974zM18.644 19.065a.498.498 0 100-.996.498.498 0 000 .996zM20.551 18.461a.498.498 0 100-.996.498.498 0 000 .996zM23.87 48.901a.498.498 0 10-.993.073.498.498 0 00.993-.073zM22.269 50.1a.498.498 0 10.072.994.498.498 0 00-.072-.994zM20.79 49.487a.498.498 0 10.072.993.498.498 0 00-.072-.993zM22.41 47.385a.498.498 0 10.994-.073.498.498 0 00-.993.073zM21.18 47.61a.498.498 0 10.072.994.498.498 0 00-.072-.993zM18.676 16.562a.498.498 0 10.934-.348.498.498 0 00-.934.348zM14.854 39.586a.498.498 0 100-.997.498.498 0 000 .997zM15.8 43.505a.498.498 0 10-.072-.993.498.498 0 00.072.993zM17.084 40.175a.498.498 0 10-.991-.098.498.498 0 00.991.098zM16.189 38.41a.498.498 0 100-.996.498.498 0 000 .996zM15.417 41.84a.498.498 0 100-.996.498.498 0 000 .997zM17.218 42.632a.498.498 0 100-.997.498.498 0 000 .997zM13.37 35.253a.498.498 0 100-.996.498.498 0 000 .996zM49.084 22.632a.498.498 0 10.617.781.498.498 0 00-.617-.781zM50.237 24.878a.497.497 0 10.782-.614.497.497 0 00-.782.614zM45.455 19.456a.498.498 0 10-.616-.781.498.498 0 00.616.781zM47.968 22.41a.498.498 0 10-.616-.78.498.498 0 00.616.78zM44.428 24.595a.498.498 0 10.616.781.498.498 0 00-.616-.781zM46.643 19.785a.498.498 0 10.616.781.498.498 0 00-.616-.781zM43.84 20.982a.497.497 0 10.781-.617.497.497 0 10-.781.617zM45.445 23.155a.498.498 0 10.617.782.498.498 0 00-.617-.782zM47.057 24.12a.497.497 0 10.781-.614.497.497 0 00-.781.614zM45.431 22.146a.497.497 0 10.782-.617.497.497 0 10-.782.617zM23.47 16.052a.498.498 0 10.997 0 .498.498 0 00-.996 0z\" fill=\"#000\"></path><path d=\"M32 9.223C16.56 9.223 4 19.44 4 32s12.56 22.777 28 22.777c15.438 0 27.998-10.217 27.998-22.777S47.438 9.223 32 9.223zm0 45.268C16.718 54.49 4.285 44.4 4.285 32 4.286 19.598 16.72 9.51 32 9.51c15.28 0 27.713 10.088 27.713 22.49S47.28 54.49 31.999 54.49z\" fill=\"#000\"></path><path d=\"M20.474 43.53c-.633 0-.633.982 0 .982s.633-.982 0-.982zM22.063 44.815c-.633 0-.633.982 0 .982s.633-.982 0-.982zM23.804 44.34c-.633 0-.633.982 0 .982s.633-.982 0-.982zM19.265 25.229c.633 0 .633-.982 0-.982s-.633.982 0 .982zM26.64 18.624c.634 0 .634-.982 0-.982-.632 0-.632.982 0 .982zM24.925 18.14c-.633 0-.633.982 0 .982s.633-.982 0-.982zM29.206 16.432c-.633 0-.633.982 0 .982s.633-.982 0-.982zM31.105 16.432c-.633 0-.633.982 0 .982s.633-.982 0-.982zM34.036 17.08c.633 0 .633-.982 0-.982s-.633.982 0 .982zM42.333 21.879c.633 0 .633-.982 0-.982s-.633.982 0 .982zM39.453 18.273c-.633 0-.633.982 0 .982s.633-.982 0-.982zM35.813 17.008c-.633 0-.633.982 0 .982s.633-.982 0-.982zM43.673 23.527c.633 0 .633-.982 0-.982s-.633.982 0 .982zM42.463 44.949c.633 0 .633-.982 0-.982s-.633.982 0 .982zM36.468 38.162a.498.498 0 100 .997.498.498 0 000-.997zM36.943 39.586a.498.498 0 100 .996.498.498 0 000-.996zM37.22 43.013a.498.498 0 10-.851-.517.498.498 0 00.851.517zM36.745 44.595a.498.498 0 10-.851-.517.498.498 0 00.851.517zM35.123 37.075a.498.498 0 10.851.517.498.498 0 00-.85-.517zM36.547 36.443a.498.498 0 10.851.516.498.498 0 00-.851-.516zM35.342 41.944c.633 0 .633-.983 0-.983s-.633.983 0 .983zM25.778 28.582a.498.498 0 10-.156.983.498.498 0 00.156-.983zM25.462 26.684a.498.498 0 10-.156.983.498.498 0 00.156-.983zM27.222 28.14a.498.498 0 100-.997.498.498 0 000 .996zM24.373 25.925a.498.498 0 100-.997.498.498 0 000 .997zM22.79 30.037a.498.498 0 100-.997.498.498 0 000 .997zM24.215 30.512a.498.498 0 100-.997.498.498 0 000 .997zM23.581 28.297a.498.498 0 10.001-.996.498.498 0 000 .996zM28.171 26.083a.498.498 0 100-.997.498.498 0 000 .997zM33.013 27.19a.498.498 0 100-.996.498.498 0 000 .996zM35.188 28.462a.498.498 0 100-.997.498.498 0 000 .997zM31.143 27.603a.498.498 0 100-.997.498.498 0 000 .997zM30.141 28.947a.498.498 0 100-.996.498.498 0 000 .996zM33.572 28.59a.498.498 0 10-.996 0 .498.498 0 00.996 0zM27.855 29.47a.498.498 0 10.996 0 .498.498 0 00-.996 0zM28.459 27.33a.498.498 0 10.997 0 .498.498 0 00-.997 0zM35.501 26.602a.498.498 0 100-.997.498.498 0 000 .997zM33.827 25.487a.498.498 0 100-.997.498.498 0 000 .997zM30.712 25.825a.498.498 0 100-.996.498.498 0 000 .996zM29.554 24.634a.498.498 0 10-.617-.78.498.498 0 00.617.78zM29.983 30.845a.498.498 0 100-.996.498.498 0 000 .996zM27.696 31.21a.498.498 0 10.997 0 .498.498 0 00-.997 0zM26.114 30.736a.498.498 0 10.997 0 .498.498 0 00-.997 0zM36.212 32.864a.497.497 0 10-.982-.156.497.497 0 00.982.156zM37.794 33.654a.498.498 0 10-.983-.155.498.498 0 00.983.155zM36.054 29.7a.497.497 0 10-.983-.156.497.497 0 00.983.156zM35.42 31.282a.498.498 0 10-.983-.156.498.498 0 00.983.156zM37.478 31.44a.498.498 0 10-.983-.155.498.498 0 00.983.155zM33.68 30.491a.498.498 0 10-.983-.156.498.498 0 00.983.156zM31.939 31.44a.498.498 0 10-.983-.156.498.498 0 00.983.156zM31.939 29.384a.498.498 0 10-.983-.156.498.498 0 00.983.156zM36.42 25.324a.498.498 0 10.157-.983.498.498 0 00-.156.983zM33.32 22.1a.498.498 0 10.001-.996.498.498 0 000 .997zM31.234 22.195a.498.498 0 10.997 0 .498.498 0 00-.997 0zM29.84 23.27a.498.498 0 100-.997.498.498 0 000 .996zM28.256 22.479a.498.498 0 100-.997.498.498 0 000 .997zM27.465 24.06a.498.498 0 100-.997.498.498 0 000 .997zM25.725 24.218a.498.498 0 100-.996.498.498 0 000 .996zM26.516 25.958a.498.498 0 100-.997.498.498 0 000 .997zM33.436 23.64a.498.498 0 100-.997.498.498 0 000 .996zM35.951 22.891a.498.498 0 10.997 0 .498.498 0 00-.997 0zM34.685 21.784a.498.498 0 10.996 0 .498.498 0 00-.996 0zM31.577 24.483a.498.498 0 10.156-.984.498.498 0 00-.156.984zM30.31 21.794a.498.498 0 10.156-.984.498.498 0 00-.156.984zM37.907 24.483a.498.498 0 10.156-.984.498.498 0 00-.156.984zM34.69 23.586a.498.498 0 10.983.155.498.498 0 00-.983-.155zM32.858 33.265a.498.498 0 10-.996 0 .498.498 0 00.996 0zM31.434 33.74a.498.498 0 10-.996 0 .498.498 0 00.997 0zM28.48 34.175a.498.498 0 00.517-.85.498.498 0 00-.517.85zM26.58 33.384a.498.498 0 00.518-.85.498.498 0 00-.517.85zM33.945 31.92a.498.498 0 00-.517.85.498.498 0 00.517-.85zM34.578 33.344a.498.498 0 00-.517.85.498.498 0 00.517-.85zM41.224 30.097a.5.5 0 10-.59-.805.5.5 0 00.59.805zM39.008 28.357a.5.5 0 10-.59-.805.5.5 0 00.59.805zM40.674 28.579a.5.5 0 10-.59-.806.5.5 0 00.59.806zM40.32 26.947a.5.5 0 10-.59-.806.5.5 0 00.59.806zM37.943 26.547a.5.5 0 00-.587-.806.5.5 0 00.587.806zM39.24 25.726a.5.5 0 10-.59-.806.5.5 0 00.59.806zM37.302 28.013a.497.497 0 10-.702-.704.497.497 0 00.702.704zM39.813 29.885a.497.497 0 10-.966.235.497.497 0 00.966-.235zM38.303 29.757a.497.497 0 10-.966.235.497.497 0 00.966-.235zM29.075 32.14c0 .632.983.632.983 0 0-.634-.983-.634-.983 0z\" fill=\"#000\"></path></svg><span>Listen to Podcasts and Articles</span></a></li></ul></div><div class=\"ExpandedNav_print__7d4vw\" data-event-element=\"print edition\"><h2 class=\"ExpandedNav_title__C8QcN ExpandedNav_printTitle__PKCL7\">The Print Edition</h2><div class=\"ExpandedNav_printContainer__Lp_nj\" data-action=\"magazine\"><a href=\"/magazine/\" data-action=\"cover\" class=\"ExpandedNav_printImgLink__gcbdt\"><img alt=\"\" loading=\"lazy\" class=\"Image_root__XxsOp Image_lazy__hYWHV ExpandedNav_printImg__hHeRU\" src=\"https://www.theatlantic.com/magazine/images/current-issue.large.jpg\" width=\"266\" height=\"200\"/></a><div class=\"ExpandedNav_printLinks__gNywy\"><div class=\"ExpandedNav_topPrintLinks__UytSB\"><a href=\"/magazine/\" data-action=\"latest\" class=\"ExpandedNav_latestIssue__iDXQm\">Latest Issue</a><a href=\"/magazine/backissues/\" data-action=\"past issues\" class=\"ExpandedNav_pastIssues__nkE14\">Past Issues</a></div><hr class=\"ExpandedNav_hr__5T2Ez\"/><a href=\"https://accounts.theatlantic.com/products/gift\" data-action=\"give a gift\" class=\"ExpandedNav_giveAGift__vyp0c\">Give a Gift</a></div></div></div></div></div></div></li><li class=\"Nav_navListItem__l2afO Nav_hideOnTablet__wyFPd Nav_searchLi__yxgD4\"><button class=\"NavSearchButton_root__DcP_y\" aria-label=\"Search The Atlantic\" aria-expanded=\"false\" aria-controls=\"nav-desktop-search\" data-event-element=\"search icon\" data-event-verb=\"opened\" data-event-surface=\"search\" data-event-module=\"search overlay\"><svg xmlns=\"http://www.w3.org/2000/svg\" viewBox=\"0 0 16 16\" class=\"NavSearchButton_searchIcon__Acpm1\" data-action=\"Open Search\"><path d=\"M15.85 15.15l-5.27-5.28a6 6 0 10-.71.71l5.28 5.27a.48.48 0 00.7 0 .48.48 0 000-.7zM1 6a5 5 0 115 5 5 5 0 01-5-5z\"></path></svg></button><div data-event-surface=\"search\" data-event-module=\"search overlay\" class=\"SearchOverlay_root__lmUcH\" hidden=\"\" id=\"nav-desktop-search\"><div data-focus-guard=\"true\" tabindex=\"0\" style=\"width:1px;height:0px;padding:0;overflow:hidden;position:fixed;top:1px;left:1px\"></div><div data-focus-lock-disabled=\"false\" aria-modal=\"true\" aria-labelledby=\"search-label\" role=\"dialog\"><form method=\"GET\" action=\"/search/\" class=\"SearchOverlay_searchForm___U0R_\" data-action=\"search submit\"><div class=\"SearchInput_root__6XLPB\"><div class=\"VisuallyHidden_root__yoK4r\"><label for=\"search-input-:R2srl2mm:\">Search The Atlantic</label></div><button type=\"submit\" title=\"Submit\" class=\"SearchInput_searchButton__u0CP0\"><svg xmlns=\"http://www.w3.org/2000/svg\" viewBox=\"0 0 16 16\" aria-hidden=\"true\" width=\"20\"><path d=\"M15.85 15.15l-5.27-5.28a6 6 0 10-.71.71l5.28 5.27a.48.48 0 00.7 0 .48.48 0 000-.7zM1 6a5 5 0 115 5 5 5 0 01-5-5z\"></path></svg></button><input type=\"search\" name=\"q\" id=\"search-input-:R2srl2mm:\" class=\"SearchInput_searchInput__5hWhI SearchInput_hideClear__re5AE\" placeholder=\"Search The Atlantic...\" autoComplete=\"off\" required=\"\"/></div><div class=\"QuickLinks_quickLinksContainer__F_iFd\"><div class=\"QuickLinks_quickLinksHeading__ms7Ht\">Quick Links</div><ul class=\"QuickLinks_quickLinksList__e7x66\"><li class=\"QuickLinks_quickLinkListItem__59_09\"><a class=\"QuickLinks_quickLink__w_Fp0\" href=\"/projects/dear-therapist/\" data-action=\"click link - quick link\" data-label=\"Dear Therapist\" data-event-element=\"quick link\" data-event-position=\"1\"><img alt=\"Dear Therapist\" loading=\"lazy\" class=\"Image_root__XxsOp Image_lazy__hYWHV QuickLinks_quickLinkImage__FTMBA\" src=\"https://cdn.theatlantic.com/media/img/specialreports/lead/2020/10/14/Thumbnail.jpg\" width=\"148\" height=\"148\"/><div class=\"QuickLinks_quickLinkLabel__TYtIC\">Dear Therapist</div></a></li><li class=\"QuickLinks_quickLinkListItem__59_09\"><a class=\"QuickLinks_quickLink__w_Fp0\" href=\"/free-daily-crossword-puzzle/\" data-action=\"click link - quick link\" data-label=\"Crossword Puzzle\" data-event-element=\"quick link\" data-event-position=\"2\"><img alt=\"Crossword Puzzle\" loading=\"lazy\" class=\"Image_root__XxsOp Image_lazy__hYWHV QuickLinks_quickLinkImage__FTMBA\" src=\"https://cdn.theatlantic.com/assets/media/files/nav-crossword.png\" width=\"148\" height=\"148\"/><div class=\"QuickLinks_quickLinkLabel__TYtIC\">Crossword Puzzle</div></a></li><li class=\"QuickLinks_quickLinkListItem__59_09\"><a class=\"QuickLinks_quickLink__w_Fp0\" href=\"/archive/\" data-action=\"click link - quick link\" data-label=\"Magazine Archive\" data-event-element=\"quick link\" data-event-position=\"3\"><img alt=\"Magazine Archive\" loading=\"lazy\" class=\"Image_root__XxsOp Image_lazy__hYWHV QuickLinks_quickLinkImage__FTMBA\" src=\"https://cdn.theatlantic.com/media/files/archive-thumbnail.png\" width=\"148\" height=\"148\"/><div class=\"QuickLinks_quickLinkLabel__TYtIC\">Magazine Archive</div></a></li><li class=\"QuickLinks_quickLinkListItem__59_09\"><a class=\"QuickLinks_quickLink__w_Fp0\" href=\"https://accounts.theatlantic.com/accounts/subscription/\" data-action=\"click link - quick link\" data-label=\"Your Subscription\" data-event-element=\"quick link\" data-event-position=\"4\"><img alt=\"Your Subscription\" loading=\"lazy\" class=\"Image_root__XxsOp Image_lazy__hYWHV QuickLinks_quickLinkImage__FTMBA\" src=\"https://cdn.theatlantic.com/media/files/YourSubscription_300x300.jpg\" width=\"148\" height=\"148\"/><div class=\"QuickLinks_quickLinkLabel__TYtIC\">Your Subscription</div></a></li></ul></div><button type=\"button\" aria-label=\"Close Search\" class=\"SearchOverlay_closeButton___zntA\" data-action=\"close search\" data-event-verb=\"closed\" data-event-element=\"close icon\"><svg viewBox=\"0 0 16 16\" xmlns=\"http://www.w3.org/2000/svg\" class=\"SearchOverlay_closeIcon__DrMMb\"><path d=\"M9.525 8l6.159 6.159a1.078 1.078 0 11-1.525 1.525L8 9.524l-6.159 6.16a1.076 1.076 0 01-1.525 0 1.078 1.078 0 010-1.525L6.476 8 .315 1.841A1.078 1.078 0 111.841.316L8 6.476l6.16-6.16a1.078 1.078 0 111.524 1.525L9.524 8z\" fill-rule=\"evenodd\"></path></svg></button></form></div><div data-focus-guard=\"true\" tabindex=\"0\" style=\"width:1px;height:0px;padding:0;overflow:hidden;position:fixed;top:1px;left:1px\"></div></div></li><li class=\"Nav_navListItem__l2afO Nav_hideOnTablet__wyFPd\"><a class=\"Nav_navLink__34Bol\" href=\"/most-popular/\" data-action=\"popular\">Popular</a></li><li class=\"Nav_navListItem__l2afO Nav_hideOnTablet__wyFPd\"><a class=\"Nav_navLink__34Bol\" href=\"/latest/\" data-action=\"latest\">Latest</a></li><li class=\"Nav_navListItem__l2afO Nav_hideOnTablet__wyFPd\"><a class=\"Nav_navLink__34Bol\" href=\"/newsletters/\" data-action=\"newsletters\">Newsletters</a></li></ul><div aria-hidden=\"true\" class=\"Nav_middleContainer__7JzLF\" data-event-element=\"wordmark\"><a href=\"/\" class=\"Nav_hideAboveMobile__1lhmL Nav_mobileBigALink__eWXD_\" tabindex=\"-1\" data-action=\"big a\"><svg xmlns=\"http://www.w3.org/2000/svg\" viewBox=\"0 0 87.83 134\" class=\"Nav_mobileBigA__9PTCs Nav_hideOnMobile__IESg8\"><path d=\"M24.48 95.13c-.56 0-.74-.37-.74-.93l13.08-55.88c.19-.94.93-.94 1.12 0L50.09 94.2c0 .56-.19.93-.75.93zM48.22.19a22.54 22.54 0 01-7.66 5.05c-.75.19-.94.37-1.13 1.12l-26.72 112.5c-2 9-4.67 10.66-11.77 11.22a.88.88 0 00-.94.93v2.06a.88.88 0 00.92.93h25.6a.88.88 0 00.93-.93V131a.88.88 0 00-.93-.93c-9.53 0-10.47-2.81-8.6-10.66l4.49-19.25a1.18 1.18 0 011.12-.93h26.74a1.19 1.19 0 011.13.93l5 23.18c1.12 5-.75 6.17-7.1 6.73a.88.88 0 00-.93.93v2.06a.88.88 0 00.93.93h37.62a.88.88 0 00.94-.93V131a.88.88 0 00-.94-.93c-5.79-.56-8.22-1.5-9.34-6.73L49.34.57c-.19-.56-.75-.75-1.12-.38\"></path></svg></a><a href=\"/\" class=\"Nav_navLink__34Bol\" tabindex=\"-1\" data-action=\"logo\"><svg xmlns=\"http://www.w3.org/2000/svg\" viewBox=\"0 0 214 33.24\" class=\"Nav_logo__RLN3C\"><path d=\"M39.39 13.2c-2.4 0-4.43 1.82-7 5.32-1.18 1.64-2.7 4-3.37 5-.38.51-.68.43-.47-.12l1.78-4.56 6.36-17.5C37 .62 34.46-.25 34 .62v.09c-1.09 2.32-3.12 3.08-6.75 2.95S16.32 1.52 10.8 1.52C3.88 1.52 0 5.78 0 10.8c0 2.82 1.85 4.64 4.34 4.55a2.27 2.27 0 002.41-1.81 1.2 1.2 0 00-1.56-1.43c-2.45.51-3.29-1.18-3.29-2.49 0-3.12 2.66-5.44 8.22-5.44 1.43 0 4.22.34 7.17.67-3.75 11.3-7.55 21.77-8.48 24.25a2.07 2.07 0 01-1.35 1.44c-1.34.42-1.77.46-2.61.67-1.27.3-1.06 1.35-.17 1.31 1.6-.09 3.67-.3 5.31-.3 2 0 5.61.17 6.16.21 1 .09 1.14-1.14.3-1.26-.59-.09-1.56-.25-2.49-.38-1.1-.13-1.43-.59-1.18-1.48.55-1.47 7-20.11 8.27-24 2 .25 3.71.42 4.84.5 2.33.14 4.57 0 6.5-1.41l-5.1 14.4-4.47 12.33c-.76 2 2.1 2.15 2.74.93a81.64 81.64 0 017.63-12.36c1.86-2.7 3.59-4.31 4.81-4.31.93 0 1.47.51 1.47 1.65 0 1.52-.71 3.88-2.15 7.89-1.89 5.23-2.61 6.62-3.24 6.66s-1.86-1.52-2.53-1.69a1.39 1.39 0 00-1.65.72c-.34.59-.12 2.49 2.74 2.62 3.42.16 6.33-3.34 8.35-8.94 1.39-3.8 1.73-5.74 1.73-7.13 0-2.7-1.26-3.97-3.33-3.97zm57.9 18.09c-2.15-.5-3-1.3-3-2.15l.09-1.77c0-1.3 1-20.49 1.22-23.36.17-2.11-2.24-2-3.25-.76l-2 2.57C87.89 8.9 78 21.68 73.17 27.67A11.5 11.5 0 0168 31.25c-.8.21-.72 1.06.17 1.06.71 0 2.82-.25 4.38-.25s4.43.12 5.15.16 1-.76 0-1c-2-.59-3-1-3-1.52s.46-1.22 1.56-2.74c.84-1.18 2.86-3.84 5.1-6.79H91c-.21 4.05-.46 8.31-.5 9.15a1.14 1.14 0 01-.93 1.14l-2.15.63c-.59.17-.85 1.27.08 1.23 2.11-.13 3.88-.3 4.81-.3 1.39 0 3.75.3 4.85.34s.94-.85.13-1.07zm-6-15.47c0 .76-.09 1.6-.13 2.49h-8.25c3.84-5.07 7.89-10.38 8.23-10.89s.67-.25.63.13c-.13 1.86-.34 5.27-.5 8.27zM55.08 13.5c-3.67-.17-7.76 4.09-9.7 10.5-1.9 6.2.21 8.77 2.53 8.77 1.69 0 4.51-2.19 6.07-4.72.55-.89.13-1.82-.71-.89-1.06 1.14-2.49 2.36-4 2.07-1-.17-1.94-1.9-.46-6.2 3.54-.17 7.71-2.19 8.77-5.53.92-2.88-.98-3.96-2.5-4zm.38 3.12c-.89 2.61-4 4.8-6.24 5.35 2.15-5.69 4.21-7.21 5.52-7.17.72 0 1.06.82.72 1.82zm53.94-1h3.42c.76 0 1.14-.21 1.3-.76.3-.72.13-1.06-.63-1.06h-3.42l1.65-4.38c.21-.59 0-.89-.34-.89h-1.77c-.46 0-.63.13-.84.72L107 13.83h-2.7c-.38 0-.68-.08-.93 1.06-.09.55 0 .76.55.76h2.4l-4.09 10.67a45.64 45.64 0 00-1.69 4.68c-.25 1.48.64 2.07 1.73 1.86 2.15-.38 5.23-2.62 8-6.12.76-1 .13-1.64-.63-.84a34.4 34.4 0 01-3.67 3.16c-1.1.72-1.64.21-1.26-.84zm38.04-1c.25-.59-.59-.76-2.53-1.13-.59-.13-.93.5-1.94 2.61a4 4 0 00-3.5-1.43c-3.08.08-6.88 2.86-10 7.12-2.49 3.42-3.25 5.78-2.78 8.31a3.11 3.11 0 003.08 2.52c2.32.08 4.64-2.11 7-4.52l1.48-1.48c.42-.42.8-.17.54.34a23.77 23.77 0 00-1.89 4.17c-.3 1.48.5 1.86 1.64 1.69 2.19-.29 5.61-2.32 8.23-5.94.75-1.06 0-1.65-.68-.85a26.62 26.62 0 01-3.75 3.29c-1.14.76-1.65.55-1.31-.34.17-.55.8-2.07 6.41-14.36zm-9.74 11c-2.66 2.45-4.81 4.22-6.29 4.22-1 0-1.47-.43-1.56-1.14-.25-1.86 1.44-4.68 2.83-6.58 2.4-3.16 5.36-5.78 7.25-5.78 1.31 0 2 .55 2.11 1.35.25 1.46-2.19 5.93-4.34 7.87zm58.58-12.71c-2.07 0-4.85 1.47-7.47 4.38-.84 1-.21 1.65.59.93a20.28 20.28 0 012.87-2.19c.89-.55 1.48-.13 1.22.67-.21.64-.84 2.2-1.3 3.25l-2.87 6.58c-.8 1.86-1.56 3.71-1.73 4.22-.38 1.31.29 2 1.35 2 2 0 4.77-1.65 7.42-4.6.84-1 .21-1.64-.59-.93a28 28 0 01-3.12 2.4c-.88.54-1.52.12-1.22-.68.21-.59.84-1.94 1.26-2.91l2.91-6.58c.85-1.94 1.82-4 2-4.55.32-1.28-.31-1.99-1.32-1.99zm2.53-10.21a2.39 2.39 0 00-2.53 2.15 2.09 2.09 0 001.85 2.45 2.43 2.43 0 002.49-2.11 2.08 2.08 0 00-1.81-2.49zm11.68 10.84c-3.71-.17-7.68 4.13-9.62 10.46s.17 8.77 2.62 8.77c1.69 0 4.51-2 6.2-4.72.55-.89.13-1.82-.72-.89-1.05 1.14-2.4 2.19-3.79 2.11s-2.37-2-.76-6.62c2.36-6.66 4-7.42 4.72-7.47s2.19 1.86 3.08 2.07a1.36 1.36 0 001.64-.71c.38-.72.14-2.83-3.37-3zm-23.95.29h-3.42l1.64-4.38c.22-.59 0-.89-.33-.89h-1.78c-.46 0-.63.13-.84.72l-1.73 4.55h-2.74c-.38 0-.67-.08-.93 1.06-.08.55.05.76.55.76h2.41l-4.09 10.67a43.34 43.34 0 00-1.69 4.68c-.26 1.48.63 2.07 1.73 1.86 2.15-.38 5.23-2.62 8-6.12.76-1 .13-1.64-.64-.84a34.33 34.33 0 01-3.68 3.16c-1.1.72-1.65.21-1.27-.84l4.71-12.6h3.42c.76 0 1.14-.21 1.31-.76.29-.69.12-1.03-.63-1.03zm-63.6 11.9a40.24 40.24 0 01-3.8 3.33c-1.1.72-1.64.21-1.26-.84L128.17.97c.17-.42.08-1-.51-1a58.6 58.6 0 00-6 .68c-.34.08-.51.59-.13.71l2.28.85c.46.17.51.38.21 1.14l-8.84 22.97a43.34 43.34 0 00-1.69 4.68c-.25 1.48.63 2.07 1.73 1.86 2.28-.38 5.52-2.62 8.35-6.29.76-1.01.13-1.64-.63-.84zm43.39.08l2.49-5c1.35-2.74 1.61-4 1.61-4.93 0-1.81-.93-2.74-2.83-2.74-2.66 0-4.77 2.11-8 6.66-.89 1.22-1.48 2.15-2.66 3.67-.38.47-.67.42-.46-.13l1.64-4.09a17 17 0 001.35-4.47c0-1.09-.46-1.6-1.64-1.6-1.44 0-3.25.76-6.41 4.77-1.14 1.47 0 1.64.38 1.18.63-.64 2-2.07 2.91-2.87s1.72-.55 1.39.42a18.36 18.36 0 01-.8 2.24l-5 12.27c-.68 1.69 2.53 2.07 3.08.8 1.73-4 5.52-9 7.08-11.22 2.28-3.25 4.26-5.48 5.69-5.48.76 0 1.1.42 1.1 1.22a5.83 5.83 0 01-.59 2l-3.54 7.55c-1 2-1.94 4.13-2.11 4.68-.42 1.31.3 2 1.43 2 2 0 4.77-1.65 7.43-4.6.84-1 .21-1.64-.59-.93a29 29 0 01-3.12 2.41c-.92.59-1.56.12-1.26-.72.21-.6.97-2.16 1.43-3.09z\"></path></svg></a></div><div class=\"Nav_rightContainer__CBCcP\"><ul class=\"NavAccountLinks_root__8VKLM\" data-event-element=\"account links\"><li class=\"NavAccountLinks_navListItem__Lxooj\"><a data-action=\"Sign In\" href=\"https://accounts.theatlantic.com/login/\" class=\"NavAccountLinks_navLink__ctd7M NavAccountLinks_hideOnMobile__Eokx4\">Sign In</a></li><li class=\"NavAccountLinks_navListItem__Lxooj\"><a data-action=\"Subscribe\" href=\"https://www.theatlantic.com/subscribe/navbar/\" class=\"NavAccountLinks_subscribe__2DNuJ\">Subscribe</a></li></ul></div></div></div></nav><div class=\"Nav_fixedPosPlaceholder__0nyHE\"></div><div class=\"Nav_overlay__zlKnQ\" data-testid=\"overlay\"></div><main id=\"main-content\" data-category=\"story page\" data-event-surface=\"article\" data-flatplan-layout=\"standard\"><gpt-ad class=\"GptAd_root__pAvcS Leaderboard_root__gbBIq\" format=\"leaderboard\" sizes-at-0=\"\" sizes-at-976=\"leaderboard\"></gpt-ad><article class=\"ArticleLayout_article__RHFMN article-content-body\"><header class=\"ArticleHero_root__3w7kV ArticleHero_articleStandard__2tcdv\" data-event-module=\"hero\"><div class=\"\"><div class=\"ArticleHero_defaultArticleLockup__vb8lz\"><div class=\"ArticleHero_rubric__e4rjD\"><div class=\"ArticleRubric_root__HNhbf\" id=\"rubric\" data-flatplan-rubric=\"true\"><a class=\"ArticleRubric_link__nl9hy\" href=\"https://www.theatlantic.com/health/\" data-action=\"click link - section rubric\" data-label=\"https://www.theatlantic.com/health/\" data-event-element=\"rubric\">Health</a></div></div><div class=\"ArticleHero_title__PQ4pC\"><h1 class=\"ArticleTitle_root__VrZaG\" data-flatplan-title=\"true\">It’s a Bad Time to Be a Booster Slacker</h1></div><div class=\"ArticleHero_dek__EqdkK\" data-flatplan-description=\"true\"><p class=\"ArticleDek_root__P3leE\">Americans aren’t getting the new bivalent COVID shot. What does that mean for the looming winter wave?</p></div><div class=\"ArticleHero_byline__iFT6A\"><div class=\"ArticleBylines_root__IBR5V\"><address id=\"byline\">By <a class=\"ArticleBylines_link__kNP4C\" href=\"https://www.theatlantic.com/author/yasmin-tayag/\" data-action=\"click author - byline\" data-label=\"https://www.theatlantic.com/author/yasmin-tayag/\" data-event-element=\"author\" data-flatplan-author-link=\"true\">Yasmin Tayag</a></address></div></div></div><div class=\"ArticleLeadArt_root__nRSLU\"><figure class=\"ArticleLeadFigure_root__Bj81R ArticleLeadFigure_standard__20Izv\"><div class=\"ArticleLeadFigure_media__R1npW\" data-flatplan-lead_figure_media=\"true\"><picture><img alt=\"An image of a pair of gloved hands inserting a syringe into a vaccine vial\" class=\"Image_root__XxsOp ArticleLeadArt_image__HZS4B\" sizes=\"(min-width: 976px) 976px, 100vw\" srcSet=\"https://cdn.theatlantic.com/thumbor/ypadUpmVZasWiH0UK19UIWCk-DY=/0x0:3997x2248/750x422/media/img/mt/2022/10/original-5/original.jpg 750w, https://cdn.theatlantic.com/thumbor/UjW1EycehV4idraMjXXTUzdzM3Y=/0x0:3997x2248/828x466/media/img/mt/2022/10/original-5/original.jpg 828w, https://cdn.theatlantic.com/thumbor/v0GNZffQTN6fPf-jrigYoEaENJ8=/0x0:3997x2248/960x540/media/img/mt/2022/10/original-5/original.jpg 960w, https://cdn.theatlantic.com/thumbor/_VN9lLez7t_KGDXf5AFrwYIjXH0=/0x0:3997x2248/976x549/media/img/mt/2022/10/original-5/original.jpg 976w, https://cdn.theatlantic.com/thumbor/iRjqgy5ntF48AWXHpMjk2PCkLuM=/0x0:3997x2248/1952x1098/media/img/mt/2022/10/original-5/original.jpg 1952w\" src=\"https://cdn.theatlantic.com/thumbor/v0GNZffQTN6fPf-jrigYoEaENJ8=/0x0:3997x2248/960x540/media/img/mt/2022/10/original-5/original.jpg\" id=\"article-lead-image\" width=\"960\" height=\"540\"/></picture></div><figcaption class=\"ArticleLeadFigure_caption__Byu7W ArticleLeadFigure_standardCaption__PsDkd\" data-flatplan-lead_figure_caption=\"true\">DANIEL LEAL / AFP / Getty</figcaption></figure></div></div><div class=\"ArticleHero_articleUtilityBar__JbQFj\"><div class=\"ArticleHero_timestamp__bKhcB\"><time class=\"ArticleTimestamp_root__b3bL6\" dateTime=\"2022-10-25T18:27:00Z\" data-flatplan-timestamp=\"true\">October 25, 2022</time></div><div class=\"ArticleHero_articleUtilityBarTools__ZHw8s\"><div class=\"ArticleShare_root__Mq0RB\"><button class=\"ArticleShare_text__oQKBy ArticleShare_shareButton__X0cIe\" aria-haspopup=\"true\" aria-controls=\":R1i5ioomm:\" aria-expanded=\"false\" aria-label=\"Open Share Menu\" data-action=\"click share - expand\" data-event-verb=\"shared\" data-event-element=\"share dropdown\">Share<svg width=\"15\" height=\"15\" fill=\"none\" xmlns=\"http://www.w3.org/2000/svg\" class=\"ArticleShare_shareIcon__G4iq1\"><path fill-rule=\"evenodd\" clip-rule=\"evenodd\" d=\"M7.335.272a.25.25 0 01.337 0l4.623 4.204a.25.25 0 01.017.353l-.336.37a.25.25 0 01-.353.016L8.004 1.926v7.9a.25.25 0 01-.25.25h-.5a.25.25 0 01-.25-.25V1.924l-3.62 3.291a.25.25 0 01-.353-.016l-.336-.37a.25.25 0 01.016-.353L7.335.272zM.5 7.545a.25.25 0 00-.25.25v6.75c0 .138.112.25.25.25h14a.25.25 0 00.25-.25v-6.75a.25.25 0 00-.25-.25H14a.25.25 0 00-.25.25v6H1.25v-6a.25.25 0 00-.25-.25H.5z\" fill=\"#000\"></path></svg></button></div><button class=\"ArticleSave_text__PMSa1 ArticleSave_saveButton__96kFU\">Save<!-- --> <svg width=\"12\" height=\"16\" fill=\"none\" xmlns=\"http://www.w3.org/2000/svg\" class=\"ArticleSaveIcon_icon__MuReP ArticleSaveIcon_unsaved___N_6I ArticleSave_bookmarkIcon__H5WvD\"><path fill-rule=\"evenodd\" clip-rule=\"evenodd\" d=\"M6 10.828l5 3.31V1H1v13.139l5-3.31zM.776 15.486A.5.5 0 010 15.07V.5A.5.5 0 01.5 0h11a.5.5 0 01.5.5v14.57a.5.5 0 01-.776.416L6.138 12.12a.25.25 0 00-.276 0L.776 15.486z\" fill=\"currentColor\"></path><path fill-rule=\"evenodd\" clip-rule=\"evenodd\" d=\"M5.572 8.75c0 .138.111.25.25.25h.5a.25.25 0 00.25-.25V6.57H8.75A.25.25 0 009 6.32v-.5a.25.25 0 00-.25-.25H6.572V3.25a.25.25 0 00-.25-.25h-.5a.25.25 0 00-.25.25v2.32H3.25a.25.25 0 00-.25.25v.5c0 .138.112.25.25.25h2.322v2.18z\" fill=\"currentColor\"></path></svg></button></div></div><gpt-ad class=\"GptAd_root__pAvcS ArticleInjector_root__I7x9v LeadArticleAd_root__tdCqm s-native s-native--standard s-native--streamline\" format=\"injector\" sizes-at-0=\"mobile-wide\" targeting-pos=\"injector-article-start\" sizes-at-976=\"desktop-wide\"></gpt-ad><div class=\"ArticleInjector_clsAvoider__dqIAm\" style=\"--placeholderHeight:298px\"></div></header><section class=\"ArticleBody_root__2gF81\" data-event-module=\"article body\" data-flatplan-body=\"true\"><p class=\"ArticleParagraph_root__4mszW\" data-flatplan-paragraph=\"true\">And just like that, with the passing of Labor Day, fall was upon us. Seemingly overnight, six-packs of pumpkin beer materialized on grocery shelves, hordes of city dwellers descended upon apple orchards—and America rolled out new COVID boosters. The timing wasn’t a coincidence. Since the beginning of the pandemic, cases in North America and Europe have risen during the fall and winter, and there was no reason to expect anything different this year. Spreading during colder weather is simply what respiratory diseases like COVID do. The hope for the fall booster rollout was that Americans would take it as an opportunity to supercharge their immunological defenses against the coronavirus in advance of a winter wave that <em>we know is going to come</em>.</p><p class=\"ArticleParagraph_root__4mszW\" data-flatplan-paragraph=\"true\">So far, reality isn’t living up to that hope. Since the new booster became available in early September, <a data-event-element=\"inline link\" href=\"https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-people-second-booster-pop50\">fewer than 20 million Americans</a> have gotten the shot, according to the CDC—just 8.5 percent of those who are eligible. The White House COVID-19 response coordinator, Ashish Jha, said at a <a data-event-element=\"inline link\" href=\"https://www.whitehouse.gov/briefing-room/press-briefings/2022/10/11/press-briefing-by-press-secretary-karine-jean-pierre-and-covid-19-response-coordinator-dr-ashish-jha-5/\">press conference earlier this month</a> that he expects booster uptake to increase in October as the temperatures drop and people start taking winter diseases more seriously. That doesn’t seem to be happening yet. America’s booster campaign is going so badly that by late September, <a data-event-element=\"inline link\" href=\"https://www.kff.org/coronavirus-covid-19/press-release/half-of-public-has-heard-little-or-nothing-about-the-new-covid-19-booster-aimed-at-omicron-many-dont-know-if-the-cdc-recommends-that-they-get-the-new-booster/\">only half of Americans had heard even “some”</a> information about the bivalent boosters, according to a recent survey. The low numbers are especially unfortunate because the remaining 91.5 percent of booster-eligible people have already shown that they’re open to vaccines by getting at least their first two shots—if not already at least one booster.</p><p class=\"ArticleParagraph_root__4mszW\" data-flatplan-paragraph=\"true\">Now the bungled booster rollout could soon run headfirst into the winter wave. The virus is not yet surging in the United States—at least as far as we can tell—but as the weather cools down, cases have been on the rise in <a data-event-element=\"inline link\" href=\"https://www.theatlantic.com/health/archive/2022/10/europe-covid-cases-variants-winter-surge/671807/\">Western Europe</a>, which has previously foreshadowed what happens in the U.S. At the same time, new Omicron offshoots such as <a data-event-element=\"inline link\" href=\"https://covid.cdc.gov/covid-data-tracker/#variant-proportions\">BQ.1 and BQ.1.1</a> are gaining traction in the U.S., and others, including XBB, are creating problems in Singapore. Boosters are our best chance at protecting ourselves from getting swept up in whatever this virus throws at us next, but too few of us are getting them. What will happen if that doesn’t change?</p><p class=\"ArticleParagraph_root__4mszW\" data-flatplan-paragraph=\"true\">The whole reason for new shots is that though the protection conferred by the original vaccines is tremendous, it has waned <a data-event-element=\"inline link\" href=\"https://www.cdc.gov/mmwr/volumes/71/wr/mm7142a3.htm\">over time and with new variants</a>. The latest booster, which is called “bivalent” because it targets both the original SARS-CoV-2 virus and BA.5, is meant to <a data-event-element=\"inline link\" href=\"https://www.biorxiv.org/content/10.1101/2022.09.21.508818v1.full\">kick-start</a> the production of more neutralizing antibodies, which in turn should prevent new infection in the short term, Katelyn Jetelina, a public-health expert who writes the newsletter <a data-event-element=\"inline link\" href=\"https://yourlocalepidemiologist.substack.com/\">Your Local Epidemiologist</a>, told me. The other two goals for the vaccine are still being studied: The hope is that it will also <a data-event-element=\"inline link\" href=\"https://www.nature.com/articles/d41586-022-03119-3\">broaden protection</a> by teaching the immune system to recognize other aspects of the virus, and that it will make protection longer-lasting.</p><p class=\"ArticleParagraph_root__4mszW\" data-flatplan-paragraph=\"true\">In theory, this souped-up booster would make a big difference heading into another wave. In September, a <a data-event-element=\"inline link\" href=\"https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2022-09-01/08-COVID-Oliver-508.pdf\">forecast</a> presented by the Advisory Committee on Immunization Practices (ACIP), which advises the CDC, showed that if people get the bivalent booster at the same rate as they do the flu vaccine—optimistic, given that about 50 percent of people have gotten the flu vaccine in recent years—roughly 25 million infections, 1 million hospitalizations, and 100,000 deaths could be averted by the end of March 2023.</p><p class=\"ArticleParagraph_root__4mszW\" data-flatplan-paragraph=\"true\">But these numbers shouldn’t be taken as gospel, because protection across the population varies widely and modeling can’t account for all of the nuance that happens in real life. Gaming out exactly what our dreadful booster rates mean going forward is not a simple endeavor “given that the immune landscape is becoming more and more complex,” Jetelina told me. People received their first shots and boosters at different times, if they got them at all. And the same is true of infections over the past year, with the added wrinkle that those who fell sick all didn’t get the same type of Omicron. All of these factors play a role in how much America’s immunological guardrails will hold up in the coming months. “But it’s very clear that a high booster rate would certainly help this winter,” Jetelina said.</p><p class=\"ArticleParagraph_root__4mszW\" data-flatplan-paragraph=\"true\">At this point in the pandemic, getting COVID is far less daunting for healthy people than it was a year or two ago (although the prospect of developing long COVID still looms). The biggest concerns are hospitalizations and deaths, which make low booster uptake among vulnerable groups such as the elderly and immunocompromised especially worrying. That said, everyone ages 5 and up who has received their primary vaccine is encouraged to get the new booster. It bears repeating that vaccination not only protects against severe illness and death but has the secondary effect of preventing transmission, thereby reducing the chances of infecting the vulnerable.</p><p class=\"ArticleParagraph_root__4mszW\" data-flatplan-paragraph=\"true\">What will happen next is hard to predict, Michael Osterholm, an epidemiologist at the University of Minnesota, told me, but now is a bad time for booster rates to be this low. Conditions are ripe for COVID’s spread. Protection is waning among the unboosted, immunity-dodging variants are emerging, and Americans just don’t seem to care about COVID anymore, Osterholm explained. The combination of these factors, he said, is “not a pretty picture.” By skipping boosters, people are missing out on the chance to offset these risks, though non-vaccine interventions such as masking and ventilation improvements can help too.</p><p class=\"ArticleParagraph_root__4mszW\" data-flatplan-paragraph=\"true\">That’s not to say that the immunity conferred by vaccination and the initial boosters is moot. Earlier doses still offer “pretty substantial protection,” Saad Omer, a Yale epidemiologist, told me. Not only are eligible Americans slacking on booster uptake, but lately vaccine uptake among the unvaccinated hasn’t risen much either. Before the new bivalent shots came around, less than half of eligible Americans had gotten a booster. “That means we are, as a population, much more vulnerable going into this fall,” James Lawler, an infectious-diseases expert at the University of Nebraska Medical Center, told me.</p><p class=\"ArticleParagraph_root__4mszW\" data-flatplan-paragraph=\"true\">If booster uptake—and vaccine uptake overall—remains low, expecting more illness, particularly among the vulnerable, would be reasonable, William Schaffner, a professor of infectious diseases at Vanderbilt University Medical Center, told me. Hospitalizations will rise more than they would otherwise, and with them the stress on the health-care system, which will also be grappling with the <a data-event-element=\"inline link\" href=\"https://www.cdc.gov/flu/about/burden/index.html\">hundreds of thousands of people</a> likely to be hospitalized for flu. While Omicron causes relatively minor symptoms, “it’s quite capable of producing severe disease,” Schaffner said. Since August, it has killed an average of <a data-event-element=\"inline link\" href=\"https://coronavirus.jhu.edu/region/united-states\">300 to 400 people each day</a>.</p><p class=\"ArticleParagraph_root__4mszW\" data-flatplan-paragraph=\"true\">All of this assumes that we won’t get a completely new variant, of course. So far, the BA.5 subvariant targeted by the bivalent booster is still dominating cases around the world. Newer ones, such as XBB, BQ.1.1, and BQ.1, are steadily gaining traction, but they’re still offshoots of Omicron. “We’re still very hopeful that the booster will be effective,” Jetelina said. But the odds of what she called an “Omicron-like event,” in which a completely new SARS-CoV-2 lineage—one that warrants a new Greek letter—emerges out of left field, are about 20 to 30 percent, she estimated. Even in this case, the bivalent nature of the booster would come in handy, helping protect against a wider crop of potential variants. The effectiveness of our shots against a brand-new variant depends on its mutations, and how much they overlap with those we’ve already seen, so “we’ll see,” Omer said.</p><p class=\"ArticleParagraph_root__4mszW\" data-flatplan-paragraph=\"true\">Just as it isn’t too late to get boosted, there’s still time to improve uptake in advance of a wave. If you’re <a data-event-element=\"inline link\" href=\"https://www.theatlantic.com/health/archive/2022/08/fall-covid-vaccine-new-booster-shot-omicron/671265/\">three to six months</a> out from an infection or your last shot, the best thing you can do for your immune system right now is to get another dose, and do it soon. Though there’s no perfect and easy solution that can overcome widespread vaccine fatigue, that doesn’t mean trying isn’t worthwhile. “Right now, we don’t have a lot of people that feel the pandemic is that big of a problem,” and people are more likely to get vaccinated if they feel their health is challenged, Osterholm said.</p><p class=\"ArticleParagraph_root__4mszW\" data-flatplan-paragraph=\"true\">There’s also plenty of room to crank the volume on the messaging in general: Not long ago, the initial vaccine campaign involved blasting social media with <a data-event-element=\"inline link\" href=\"https://www.vulture.com/2021/03/celebrities-who-got-the-covid-19-vaccine.html\">celebrity endorsers</a> such as Dolly Parton and Olivia Rodrigo. Where is that now? Lots of pharmacies are swimming in vaccines, but making getting boosted even easier and more convenient can go a long way too. “We need to catch them where they come,” said Omer, who thinks boosters should be offered at workplaces, in churches and community centers, and at specialty clinics such as dialysis centers where patients are vulnerable by default.</p><p class=\"ArticleParagraph_root__4mszW\" data-flatplan-paragraph=\"true\">After more than two years of covering and living through the pandemic, believe me: I get that people are over it. It’s easy not to care when the risks of COVID seem to be negligible. But while shedding masks is one thing, taking a blasé attitude toward boosters is another. Shots alone can’t solve all of our pandemic problems, but their unrivaled protective effects are fading. Without a re-up, when the winter wave reaches U.S. shores and more people start getting sick, the risks may no longer be so easy to ignore.</p><div class=\"ArticleBody_divider__GpNxD\" id=\"article-end\"></div></section><div data-event-module=\"footer\"><div class=\"ArticleWell_root__fueCa\"><div><address id=\"article-writer-0\" class=\"ArticleBio_root__ua8zj\" data-event-element=\"author\" data-flatplan-bio=\"true\"><div class=\"ArticleBio_content__O0ZVF\"><div class=\"ArticleBio_bio__DXQnd\" data-flatplan-bio=\"true\"><a href=\"https://www.theatlantic.com/author/yasmin-tayag/\" class=\"author-link\" data-label=\"https://www.theatlantic.com/author/yasmin-tayag/\" data-action=\"click author - name\"  >Yasmin Tayag</a> is a staff writer at <em>The Atlantic</em>.</div></div></address></div></div><div></div></div><gpt-ad class=\"GptAd_root__pAvcS ArticleInjector_root__I7x9v s-native s-native--standard s-native--streamline\" format=\"injector\" sizes-at-0=\"mobile-wide,native,house\" targeting-pos=\"injector-most-popular\" sizes-at-976=\"desktop-wide,native,house\"></gpt-ad><div class=\"ArticleInjector_clsAvoider__dqIAm\"></div></article><div></div></main><div></div><div></div></div></div><script id=\"__NEXT_DATA__\" type=\"application/json\">{\"props\":{\"isLoggedIn\":false,\"hasPaywallAccess\":false,\"hasAdFree\":false,\"pageProps\":{\"id\":\"BlogArticle:671860\",\"isTnfCompatible\":true,\"layout\":\"standard\",\"hasMeter\":true,\"url\":\"https://www.theatlantic.com/health/archive/2022/10/americas-covid-booster-rates-are-a-bad-sign-for-winter/671860/\",\"dateModified\":\"2022-10-26T11:26:26Z\",\"__typename\":\"BlogArticle\",\"notFound\":false,\"urqlState\":{\"350207859\":{\"data\":\"{\\\"article\\\":{\\\"primaryCategory\\\":{\\\"__typename\\\":\\\"Channel\\\"},\\\"editorialProject\\\":null,\\\"__typename\\\":\\\"BlogArticle\\\"}}\"},\"363224348\":{\"data\":\"{\\\"article\\\":{\\\"id\\\":\\\"BlogArticle:671860\\\",\\\"isTnfCompatible\\\":true,\\\"layout\\\":\\\"standard\\\",\\\"hasMeter\\\":true,\\\"url\\\":\\\"https://www.theatlantic.com/health/archive/2022/10/americas-covid-booster-rates-are-a-bad-sign-for-winter/671860/\\\",\\\"dateModified\\\":\\\"2022-10-26T11:26:26Z\\\",\\\"__typename\\\":\\\"BlogArticle\\\"}}\"},\"1586028085\":{\"data\":\"{\\\"article\\\":{\\\"__typename\\\":\\\"BlogArticle\\\",\\\"id\\\":\\\"BlogArticle:671860\\\",\\\"categories\\\":[],\\\"content\\\":[{\\\"__typename\\\":\\\"ArticleParagraphContent\\\",\\\"subtype\\\":null,\\\"idAttr\\\":\\\"\\\",\\\"innerHtml\\\":\\\"And just like that, with the passing of Labor Day, fall was upon us. Seemingly overnight, six-packs of pumpkin beer materialized on grocery shelves, hordes of city dwellers descended upon apple orchards—and America rolled out new COVID boosters. The timing wasn’t a coincidence. Since the beginning of the pandemic, cases in North America and Europe have risen during the fall and winter, and there was no reason to expect anything different this year. Spreading during colder weather is simply what respiratory diseases like COVID do. The hope for the fall booster rollout was that Americans would take it as an opportunity to supercharge their immunological defenses against the coronavirus in advance of a winter wave that \\u003cem\\u003ewe know is going to come\\u003c/em\\u003e.\\\"},{\\\"__typename\\\":\\\"ArticleParagraphContent\\\",\\\"subtype\\\":null,\\\"idAttr\\\":\\\"\\\",\\\"innerHtml\\\":\\\"So far, reality isn’t living up to that hope. Since the new booster became available in early September, \\u003ca data-event-element=\\\\\\\"inline link\\\\\\\" href=\\\\\\\"https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-people-second-booster-pop50\\\\\\\"\\u003efewer than 20 million Americans\\u003c/a\\u003e have gotten the shot, according to the CDC—just 8.5 percent of those who are eligible. The White House COVID-19 response coordinator, Ashish Jha, said at a \\u003ca data-event-element=\\\\\\\"inline link\\\\\\\" href=\\\\\\\"https://www.whitehouse.gov/briefing-room/press-briefings/2022/10/11/press-briefing-by-press-secretary-karine-jean-pierre-and-covid-19-response-coordinator-dr-ashish-jha-5/\\\\\\\"\\u003epress conference earlier this month\\u003c/a\\u003e that he expects booster uptake to increase in October as the temperatures drop and people start taking winter diseases more seriously. That doesn’t seem to be happening yet. America’s booster campaign is going so badly that by late September, \\u003ca data-event-element=\\\\\\\"inline link\\\\\\\" href=\\\\\\\"https://www.kff.org/coronavirus-covid-19/press-release/half-of-public-has-heard-little-or-nothing-about-the-new-covid-19-booster-aimed-at-omicron-many-dont-know-if-the-cdc-recommends-that-they-get-the-new-booster/\\\\\\\"\\u003eonly half of Americans had heard even “some”\\u003c/a\\u003e information about the bivalent boosters, according to a recent survey. The low numbers are especially unfortunate because the remaining 91.5 percent of booster-eligible people have already shown that they’re open to vaccines by getting at least their first two shots—if not already at least one booster.\\\"},{\\\"__typename\\\":\\\"ArticleParagraphContent\\\",\\\"subtype\\\":null,\\\"idAttr\\\":\\\"\\\",\\\"innerHtml\\\":\\\"Now the bungled booster rollout could soon run headfirst into the winter wave. The virus is not yet surging in the United States—at least as far as we can tell—but as the weather cools down, cases have been on the rise in \\u003ca data-event-element=\\\\\\\"inline link\\\\\\\" href=\\\\\\\"https://www.theatlantic.com/health/archive/2022/10/europe-covid-cases-variants-winter-surge/671807/\\\\\\\"\\u003eWestern Europe\\u003c/a\\u003e, which has previously foreshadowed what happens in the U.S. At the same time, new Omicron offshoots such as \\u003ca data-event-element=\\\\\\\"inline link\\\\\\\" href=\\\\\\\"https://covid.cdc.gov/covid-data-tracker/#variant-proportions\\\\\\\"\\u003eBQ.1 and BQ.1.1\\u003c/a\\u003e are gaining traction in the U.S., and others, including XBB, are creating problems in Singapore. Boosters are our best chance at protecting ourselves from getting swept up in whatever this virus throws at us next, but too few of us are getting them. What will happen if that doesn’t change?\\\"},{\\\"__typename\\\":\\\"ArticleParagraphContent\\\",\\\"subtype\\\":null,\\\"idAttr\\\":\\\"\\\",\\\"innerHtml\\\":\\\"The whole reason for new shots is that though the protection conferred by the original vaccines is tremendous, it has waned \\u003ca data-event-element=\\\\\\\"inline link\\\\\\\" href=\\\\\\\"https://www.cdc.gov/mmwr/volumes/71/wr/mm7142a3.htm\\\\\\\"\\u003eover time and with new variants\\u003c/a\\u003e. The latest booster, which is called “bivalent” because it targets both the original SARS-CoV-2 virus and BA.5, is meant to \\u003ca data-event-element=\\\\\\\"inline link\\\\\\\" href=\\\\\\\"https://www.biorxiv.org/content/10.1101/2022.09.21.508818v1.full\\\\\\\"\\u003ekick-start\\u003c/a\\u003e the production of more neutralizing antibodies, which in turn should prevent new infection in the short term, Katelyn Jetelina, a public-health expert who writes the newsletter \\u003ca data-event-element=\\\\\\\"inline link\\\\\\\" href=\\\\\\\"https://yourlocalepidemiologist.substack.com/\\\\\\\"\\u003eYour Local Epidemiologist\\u003c/a\\u003e, told me. The other two goals for the vaccine are still being studied: The hope is that it will also \\u003ca data-event-element=\\\\\\\"inline link\\\\\\\" href=\\\\\\\"https://www.nature.com/articles/d41586-022-03119-3\\\\\\\"\\u003ebroaden protection\\u003c/a\\u003e by teaching the immune system to recognize other aspects of the virus, and that it will make protection longer-lasting.\\\"},{\\\"__typename\\\":\\\"ArticleParagraphContent\\\",\\\"subtype\\\":null,\\\"idAttr\\\":\\\"\\\",\\\"innerHtml\\\":\\\"In theory, this souped-up booster would make a big difference heading into another wave. In September, a \\u003ca data-event-element=\\\\\\\"inline link\\\\\\\" href=\\\\\\\"https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2022-09-01/08-COVID-Oliver-508.pdf\\\\\\\"\\u003eforecast\\u003c/a\\u003e presented by the Advisory Committee on Immunization Practices (ACIP), which advises the CDC, showed that if people get the bivalent booster at the same rate as they do the flu vaccine—optimistic, given that about 50 percent of people have gotten the flu vaccine in recent years—roughly 25 million infections, 1 million hospitalizations, and 100,000 deaths could be averted by the end of March 2023.\\\"},{\\\"__typename\\\":\\\"ArticleParagraphContent\\\",\\\"subtype\\\":null,\\\"idAttr\\\":\\\"\\\",\\\"innerHtml\\\":\\\"But these numbers shouldn’t be taken as gospel, because protection across the population varies widely and modeling can’t account for all of the nuance that happens in real life. Gaming out exactly what our dreadful booster rates mean going forward is not a simple endeavor “given that the immune landscape is becoming more and more complex,” Jetelina told me. People received their first shots and boosters at different times, if they got them at all. And the same is true of infections over the past year, with the added wrinkle that those who fell sick all didn’t get the same type of Omicron. All of these factors play a role in how much America’s immunological guardrails will hold up in the coming months. “But it’s very clear that a high booster rate would certainly help this winter,” Jetelina said.\\\"},{\\\"__typename\\\":\\\"ArticleParagraphContent\\\",\\\"subtype\\\":null,\\\"idAttr\\\":\\\"\\\",\\\"innerHtml\\\":\\\"At this point in the pandemic, getting COVID is far less daunting for healthy people than it was a year or two ago (although the prospect of developing long COVID still looms). The biggest concerns are hospitalizations and deaths, which make low booster uptake among vulnerable groups such as the elderly and immunocompromised especially worrying. That said, everyone ages 5 and up who has received their primary vaccine is encouraged to get the new booster. It bears repeating that vaccination not only protects against severe illness and death but has the secondary effect of preventing transmission, thereby reducing the chances of infecting the vulnerable.\\\"},{\\\"__typename\\\":\\\"ArticleParagraphContent\\\",\\\"subtype\\\":null,\\\"idAttr\\\":\\\"\\\",\\\"innerHtml\\\":\\\"What will happen next is hard to predict, Michael Osterholm, an epidemiologist at the University of Minnesota, told me, but now is a bad time for booster rates to be this low. Conditions are ripe for COVID’s spread. Protection is waning among the unboosted, immunity-dodging variants are emerging, and Americans just don’t seem to care about COVID anymore, Osterholm explained. The combination of these factors, he said, is “not a pretty picture.” By skipping boosters, people are missing out on the chance to offset these risks, though non-vaccine interventions such as masking and ventilation improvements can help too.\\\"},{\\\"__typename\\\":\\\"ArticleParagraphContent\\\",\\\"subtype\\\":null,\\\"idAttr\\\":\\\"\\\",\\\"innerHtml\\\":\\\"That’s not to say that the immunity conferred by vaccination and the initial boosters is moot. Earlier doses still offer “pretty substantial protection,” Saad Omer, a Yale epidemiologist, told me. Not only are eligible Americans slacking on booster uptake, but lately vaccine uptake among the unvaccinated hasn’t risen much either. Before the new bivalent shots came around, less than half of eligible Americans had gotten a booster. “That means we are, as a population, much more vulnerable going into this fall,” James Lawler, an infectious-diseases expert at the University of Nebraska Medical Center, told me.\\\"},{\\\"__typename\\\":\\\"ArticleParagraphContent\\\",\\\"subtype\\\":null,\\\"idAttr\\\":\\\"\\\",\\\"innerHtml\\\":\\\"If booster uptake—and vaccine uptake overall—remains low, expecting more illness, particularly among the vulnerable, would be reasonable, William Schaffner, a professor of infectious diseases at Vanderbilt University Medical Center, told me. Hospitalizations will rise more than they would otherwise, and with them the stress on the health-care system, which will also be grappling with the \\u003ca data-event-element=\\\\\\\"inline link\\\\\\\" href=\\\\\\\"https://www.cdc.gov/flu/about/burden/index.html\\\\\\\"\\u003ehundreds of thousands of people\\u003c/a\\u003e likely to be hospitalized for flu. While Omicron causes relatively minor symptoms, “it’s quite capable of producing severe disease,” Schaffner said. Since August, it has killed an average of \\u003ca data-event-element=\\\\\\\"inline link\\\\\\\" href=\\\\\\\"https://coronavirus.jhu.edu/region/united-states\\\\\\\"\\u003e300 to 400 people each day\\u003c/a\\u003e.\\\"},{\\\"__typename\\\":\\\"ArticleParagraphContent\\\",\\\"subtype\\\":null,\\\"idAttr\\\":\\\"\\\",\\\"innerHtml\\\":\\\"All of this assumes that we won’t get a completely new variant, of course. So far, the BA.5 subvariant targeted by the bivalent booster is still dominating cases around the world. Newer ones, such as XBB, BQ.1.1, and BQ.1, are steadily gaining traction, but they’re still offshoots of Omicron. “We’re still very hopeful that the booster will be effective,” Jetelina said. But the odds of what she called an “Omicron-like event,” in which a completely new SARS-CoV-2 lineage—one that warrants a new Greek letter—emerges out of left field, are about 20 to 30 percent, she estimated. Even in this case, the bivalent nature of the booster would come in handy, helping protect against a wider crop of potential variants. The effectiveness of our shots against a brand-new variant depends on its mutations, and how much they overlap with those we’ve already seen, so “we’ll see,” Omer said.\\\"},{\\\"__typename\\\":\\\"ArticleParagraphContent\\\",\\\"subtype\\\":null,\\\"idAttr\\\":\\\"\\\",\\\"innerHtml\\\":\\\"Just as it isn’t too late to get boosted, there’s still time to improve uptake in advance of a wave. If you’re \\u003ca data-event-element=\\\\\\\"inline link\\\\\\\" href=\\\\\\\"https://www.theatlantic.com/health/archive/2022/08/fall-covid-vaccine-new-booster-shot-omicron/671265/\\\\\\\"\\u003ethree to six months\\u003c/a\\u003e out from an infection or your last shot, the best thing you can do for your immune system right now is to get another dose, and do it soon. Though there’s no perfect and easy solution that can overcome widespread vaccine fatigue, that doesn’t mean trying isn’t worthwhile. “Right now, we don’t have a lot of people that feel the pandemic is that big of a problem,” and people are more likely to get vaccinated if they feel their health is challenged, Osterholm said.\\\"},{\\\"__typename\\\":\\\"ArticleParagraphContent\\\",\\\"subtype\\\":null,\\\"idAttr\\\":\\\"\\\",\\\"innerHtml\\\":\\\"There’s also plenty of room to crank the volume on the messaging in general: Not long ago, the initial vaccine campaign involved blasting social media with \\u003ca data-event-element=\\\\\\\"inline link\\\\\\\" href=\\\\\\\"https://www.vulture.com/2021/03/celebrities-who-got-the-covid-19-vaccine.html\\\\\\\"\\u003ecelebrity endorsers\\u003c/a\\u003e such as Dolly Parton and Olivia Rodrigo. Where is that now? Lots of pharmacies are swimming in vaccines, but making getting boosted even easier and more convenient can go a long way too. “We need to catch them where they come,” said Omer, who thinks boosters should be offered at workplaces, in churches and community centers, and at specialty clinics such as dialysis centers where patients are vulnerable by default.\\\"},{\\\"__typename\\\":\\\"ArticleParagraphContent\\\",\\\"subtype\\\":null,\\\"idAttr\\\":\\\"\\\",\\\"innerHtml\\\":\\\"After more than two years of covering and living through the pandemic, believe me: I get that people are over it. It’s easy not to care when the risks of COVID seem to be negligible. But while shedding masks is one thing, taking a blasé attitude toward boosters is another. Shots alone can’t solve all of our pandemic problems, but their unrivaled protective effects are fading. Without a re-up, when the winter wave reaches U.S. shores and more people start getting sick, the risks may no longer be so easy to ignore.\\\"}],\\\"editorialProject\\\":null,\\\"primaryCategory\\\":{\\\"__typename\\\":\\\"Channel\\\",\\\"displayName\\\":\\\"Health\\\",\\\"url\\\":\\\"https://www.theatlantic.com/health/\\\",\\\"slug\\\":\\\"health\\\"},\\\"reviews\\\":[],\\\"embeds\\\":[],\\\"authors\\\":[{\\\"id\\\":\\\"Author:27059\\\",\\\"displayName\\\":\\\"Yasmin Tayag\\\",\\\"url\\\":\\\"https://www.theatlantic.com/author/yasmin-tayag/\\\",\\\"biography\\\":{\\\"default\\\":\\\"\\u003ca href=\\\\\\\"https://www.theatlantic.com/author/yasmin-tayag/\\\\\\\" class=\\\\\\\"author-link\\\\\\\" data-label=\\\\\\\"https://www.theatlantic.com/author/yasmin-tayag/\\\\\\\" data-action=\\\\\\\"click author - name\\\\\\\"  \\u003eYasmin Tayag\\u003c/a\\u003e is a staff writer at \\u003cem\\u003eThe Atlantic\\u003c/em\\u003e.\\\",\\\"__typename\\\":\\\"Biography\\\"},\\\"__typename\\\":\\\"Author\\\",\\\"slug\\\":\\\"yasmin-tayag\\\",\\\"socialMedia\\\":[]}],\\\"preview\\\":null,\\\"layout\\\":\\\"standard\\\",\\\"secondaryByline\\\":\\\"\\\",\\\"dek\\\":\\\"Americans aren’t getting the new bivalent COVID shot. What does that mean for the looming winter wave?\\\",\\\"url\\\":\\\"https://www.theatlantic.com/health/archive/2022/10/americas-covid-booster-rates-are-a-bad-sign-for-winter/671860/\\\",\\\"title\\\":\\\"It’s a Bad Time to Be a Booster Slacker\\\",\\\"seoTitle\\\":\\\"America’s COVID-Booster Rates Are a Bad Sign for Winter\\\",\\\"dateModified\\\":\\\"2022-10-26T11:26:26Z\\\",\\\"datePublished\\\":\\\"2022-10-25T18:27:00Z\\\",\\\"hasMeter\\\":true,\\\"primaryChannel\\\":{\\\"displayName\\\":\\\"Health\\\",\\\"__typename\\\":\\\"Channel\\\",\\\"slug\\\":\\\"health\\\"},\\\"shareImage1x1\\\":{\\\"width\\\":1080,\\\"height\\\":1080,\\\"url\\\":\\\"https://cdn.theatlantic.com/thumbor/uVy5eRV4IxN__6jt6-rjkyrr284=/1227x0:3929x2702/1080x1080/media/img/mt/2022/10/original-5/original.jpg\\\",\\\"__typename\\\":\\\"BasicImage\\\"},\\\"shareImage16x9\\\":{\\\"width\\\":1600,\\\"height\\\":900,\\\"url\\\":\\\"https://cdn.theatlantic.com/thumbor/CveTyp4MDHY45mxtokXiwEeck1Y=/0x0:3997x2248/1600x900/media/img/mt/2022/10/original-5/original.jpg\\\",\\\"__typename\\\":\\\"BasicImage\\\"},\\\"shareImage4x3\\\":{\\\"width\\\":1200,\\\"height\\\":900,\\\"url\\\":\\\"https://cdn.theatlantic.com/thumbor/cWxDBLbrkpiEMpvggikcFZ3L3Rk=/267x0:3734x2600/1200x900/media/img/mt/2022/10/original-5/original.jpg\\\",\\\"__typename\\\":\\\"BasicImage\\\"},\\\"shareImageDefault\\\":{\\\"width\\\":960,\\\"height\\\":540,\\\"url\\\":\\\"https://cdn.theatlantic.com/thumbor/v0GNZffQTN6fPf-jrigYoEaENJ8=/0x0:3997x2248/960x540/media/img/mt/2022/10/original-5/original.jpg\\\",\\\"__typename\\\":\\\"BasicImage\\\"},\\\"shareImageSquareDefault\\\":{\\\"width\\\":540,\\\"height\\\":540,\\\"url\\\":\\\"https://cdn.theatlantic.com/thumbor/UKlL8Q9bfCzkrFh3kFhR8SNDINg=/1227x0:3929x2702/540x540/media/img/mt/2022/10/original-5/original.jpg\\\",\\\"__typename\\\":\\\"BasicImage\\\"},\\\"shareImageLeadArt\\\":{\\\"image\\\":{\\\"width\\\":720,\\\"height\\\":405,\\\"url\\\":\\\"https://cdn.theatlantic.com/thumbor/vP84RqWMxb91TvQRl76ShrQBfA8=/0x0:3997x2248/720x405/media/img/mt/2022/10/original-5/original.jpg\\\",\\\"__typename\\\":\\\"BasicImage\\\"},\\\"__typename\\\":\\\"LeadArtImage\\\"},\\\"shareDek\\\":\\\"Americans aren’t getting the new bivalent COVID shot. What does that mean for the looming winter wave?\\\",\\\"shareText\\\":\\\"America's bivalent-booster campaign has not been going according to plan. Will that make the inevitable winter COVID wave even worse? @yeahyeahyasmin investigates:\\\",\\\"shareTitle\\\":\\\"It’s a Bad Time to Be a Booster Slacker\\\",\\\"editorsNote\\\":null,\\\"leadArt\\\":{\\\"__typename\\\":\\\"LeadArtImage\\\",\\\"image\\\":{\\\"url\\\":\\\"https://cdn.theatlantic.com/thumbor/v0GNZffQTN6fPf-jrigYoEaENJ8=/0x0:3997x2248/960x540/media/img/mt/2022/10/original-5/original.jpg\\\",\\\"width\\\":960,\\\"height\\\":540,\\\"srcSet\\\":\\\"https://cdn.theatlantic.com/thumbor/ypadUpmVZasWiH0UK19UIWCk-DY=/0x0:3997x2248/750x422/media/img/mt/2022/10/original-5/original.jpg 750w, https://cdn.theatlantic.com/thumbor/UjW1EycehV4idraMjXXTUzdzM3Y=/0x0:3997x2248/828x466/media/img/mt/2022/10/original-5/original.jpg 828w, https://cdn.theatlantic.com/thumbor/v0GNZffQTN6fPf-jrigYoEaENJ8=/0x0:3997x2248/960x540/media/img/mt/2022/10/original-5/original.jpg 960w, https://cdn.theatlantic.com/thumbor/_VN9lLez7t_KGDXf5AFrwYIjXH0=/0x0:3997x2248/976x549/media/img/mt/2022/10/original-5/original.jpg 976w, https://cdn.theatlantic.com/thumbor/iRjqgy5ntF48AWXHpMjk2PCkLuM=/0x0:3997x2248/1952x1098/media/img/mt/2022/10/original-5/original.jpg 1952w\\\",\\\"reducedMotionSrcSet\\\":null,\\\"altText\\\":\\\"An image of a pair of gloved hands inserting a syringe into a vaccine vial\\\",\\\"captionText\\\":\\\"\\\",\\\"attributionText\\\":\\\"DANIEL LEAL / AFP / Getty\\\",\\\"attributionUrl\\\":\\\"\\\",\\\"__typename\\\":\\\"BasicImage\\\"}},\\\"narratedAudio\\\":null,\\\"hasAudioRights\\\":null,\\\"narratedAudioImage\\\":{\\\"url\\\":\\\"https://cdn.theatlantic.com/thumbor/RzBBBitv8veOW3XiI48MFxhTVgc=/1227x0:3929x2702/80x80/media/img/mt/2022/10/original-5/original.jpg\\\",\\\"srcSet\\\":\\\"https://cdn.theatlantic.com/thumbor/RzBBBitv8veOW3XiI48MFxhTVgc=/1227x0:3929x2702/80x80/media/img/mt/2022/10/original-5/original.jpg 80w, https://cdn.theatlantic.com/thumbor/eGsckPL8OCNee9b3dvHvo0daq_4=/1227x0:3929x2702/96x96/media/img/mt/2022/10/original-5/original.jpg 96w, https://cdn.theatlantic.com/thumbor/eNAqnKnJ-rTLE3JZcyWjJPmdqCc=/1227x0:3929x2702/128x128/media/img/mt/2022/10/original-5/original.jpg 128w, https://cdn.theatlantic.com/thumbor/OxAOtjJyTHcwwubjqVIa2fODW64=/1227x0:3929x2702/160x160/media/img/mt/2022/10/original-5/original.jpg 160w, https://cdn.theatlantic.com/thumbor/Vi-XmbWyIFUAlar96XjDmLuJP3A=/1227x0:3929x2702/192x192/media/img/mt/2022/10/original-5/original.jpg 192w, https://cdn.theatlantic.com/thumbor/_Uu4yy1OFXu__N5UMquZhBEMEmM=/1227x0:3929x2702/256x256/media/img/mt/2022/10/original-5/original.jpg 256w, https://cdn.theatlantic.com/thumbor/GI8N0IIM-qbUOGUH4aTpf_ttFAM=/1227x0:3929x2702/384x384/media/img/mt/2022/10/original-5/original.jpg 384w, https://cdn.theatlantic.com/thumbor/1Pf43paBgk1041Qc8-vViil_Ki8=/1227x0:3929x2702/512x512/media/img/mt/2022/10/original-5/original.jpg 512w\\\",\\\"width\\\":80,\\\"height\\\":80,\\\"altText\\\":\\\"An image of a pair of gloved hands inserting a syringe into a vaccine vial\\\",\\\"__typename\\\":\\\"BasicImage\\\"},\\\"fbiaUrl\\\":\\\"https://www.theatlantic.com/facebook-instant/article/671860/\\\",\\\"canonicalUrl\\\":\\\"https://www.theatlantic.com/health/archive/2022/10/americas-covid-booster-rates-are-a-bad-sign-for-winter/671860/\\\",\\\"syndication\\\":\\\"ALL\\\",\\\"shareImage2x1\\\":{\\\"url\\\":\\\"https://cdn.theatlantic.com/thumbor/V0abThj5aTxkiLt_4gWCHjDGwk0=/0x5:3996x2086/1200x625/media/img/mt/2022/10/original-5/original.jpg\\\",\\\"height\\\":625,\\\"width\\\":1200,\\\"__typename\\\":\\\"BasicImage\\\"},\\\"shareImageGift2x1\\\":{\\\"url\\\":\\\"https://cdn.theatlantic.com/thumbor/eWeIA0mdjmQ7Z2qsbAis_Xq-_UI=/0x5:3996x2086/1200x625/filters:watermark(https://cdn.theatlantic.com/media/files/badge_2x.png,-20,20,0,33)/media/img/mt/2022/10/original-5/original.jpg\\\",\\\"height\\\":625,\\\"width\\\":1200,\\\"__typename\\\":\\\"BasicImage\\\"},\\\"shareImageGiftSmall\\\":{\\\"url\\\":\\\"https://cdn.theatlantic.com/thumbor/agIuszb7B9VTjxnnTOFwPTzDagg=/8x1:3988x2090/960x504/filters:watermark(https://cdn.theatlantic.com/media/files/badge_2x.png,-20,20,0,33)/media/img/mt/2022/10/original-5/original.jpg\\\",\\\"height\\\":504,\\\"width\\\":960,\\\"__typename\\\":\\\"BasicImage\\\"},\\\"shareImageSmall\\\":{\\\"url\\\":\\\"https://cdn.theatlantic.com/thumbor/7RGTiDhX1zmJxApGgHx_IezgY0U=/8x1:3988x2090/960x504/media/img/mt/2022/10/original-5/original.jpg\\\",\\\"height\\\":504,\\\"width\\\":960,\\\"__typename\\\":\\\"BasicImage\\\"},\\\"channels\\\":[{\\\"slug\\\":\\\"health\\\",\\\"__typename\\\":\\\"Channel\\\"}],\\\"watsonInfo\\\":{\\\"keywords\\\":[\\\"new COVID boosters\\\",\\\"fall booster rollout\\\",\\\"new booster\\\",\\\"late September\\\",\\\"much America’s immunological guardrails\\\",\\\"early September\\\",\\\"booster uptake\\\",\\\"bivalent boosters\\\",\\\"immune system\\\",\\\"booster-eligible people\\\",\\\"best chance\\\",\\\"severe illness\\\",\\\"original vaccines\\\",\\\"new infection\\\",\\\"coming months\\\",\\\"America’s booster campaign\\\",\\\"vulnerable groups\\\",\\\"original SARS-CoV-2 virus\\\",\\\"six-packs of pumpkin beer\\\",\\\"Omicron causes\\\",\\\"flu vaccine\\\",\\\"community centers\\\",\\\"pandemic problems\\\",\\\"low numbers\\\",\\\"North America\\\",\\\"big difference\\\",\\\"best thing\\\",\\\"respiratory diseases\\\",\\\"secondary effect\\\",\\\"recent years\\\",\\\"new Omicron offshoots\\\",\\\"combination of these factors\\\",\\\"White House COVID-19 response coordinator\\\",\\\"people\\\",\\\"new shots\\\",\\\"lot of people\\\",\\\"healthy people\\\",\\\"vaccines\\\",\\\"Advisory Committee\\\",\\\"recent survey\\\",\\\"latest booster\\\",\\\"bivalent booster\\\",\\\"United States\\\",\\\"apple orchards\\\",\\\"press conference\\\",\\\"public-health expert\\\",\\\"past year\\\",\\\"Western Europe\\\",\\\"short term\\\",\\\"social media\\\"],\\\"__typename\\\":\\\"WatsonInfo\\\"},\\\"slug\\\":\\\"americas-covid-booster-rates-are-a-bad-sign-for-winter\\\",\\\"grapeshot\\\":{\\\"segments\\\":[\\\"pos_gucci\\\",\\\"pos_mastercard\\\",\\\"pos_oceangate\\\",\\\"pos_safe_core\\\",\\\"pos_safety_delta\\\",\\\"gs_health\\\",\\\"gs_health_misc\\\",\\\"gs_covid19\\\",\\\"shadow9hu7_pos_lexus_fy23\\\",\\\"shadow9hu7_pos_goldman_sachs\\\",\\\"shadow9hu7_pos_israel_conflict\\\",\\\"shadow9hu7_pos_bofa-kwlist\\\",\\\"gt_negative\\\"],\\\"__typename\\\":\\\"Grapeshot\\\"},\\\"tags\\\":[]}}\"},\"2021745665\":{\"data\":\"{\\\"breakingNews\\\":null}\"}},\"urqlClient\":null},\"isSocialBot\":false},\"page\":\"/[channel]/archive/[year]/[month]/[slug]/[id]\",\"query\":{\"channel\":\"health\",\"year\":\"2022\",\"month\":\"10\",\"slug\":\"americas-covid-booster-rates-are-a-bad-sign-for-winter\",\"id\":\"671860\"},\"buildId\":\"0b2c874c71\",\"assetPrefix\":\"https://cdn.theatlantic.com\",\"runtimeConfig\":{\"GTM_CONTAINER_ID\":\"GTM-NTQTB9V\",\"GTM_CONTAINER_ID_NONCONSENTED\":\"GTM-5839GV7\",\"GRAPHQL_API_URL\":\"https://graphql.theatlantic.com\",\"GRAPHQL_API_KEY\":\"JakhyMEXwa9odtB8gBxFI63ITyKqDGkn7ciGVIJf\",\"ADS_LIB_URL\":\"https://www.theatlantic.com/packages/hummingbirdjs/hummingbird.min.js\",\"ACCOUNTS_FRONTEND_URL\":\"https://accounts.theatlantic.com\",\"ENABLE_FEATURE_ARTICLE_RENDER\":\"false\",\"RECAPTCHA_SITE_KEY\":\"6Lc9Z7AUAAAAAEYS1dgAG2_6tT3KLqZQ1z4kbDRc\"},\"isFallback\":false,\"dynamicIds\":[46449,52839],\"gip\":true,\"appGip\":true,\"scriptLoader\":[]}</script><script nomodule=\"\" src=\"https://cdn.theatlantic.com/_next/static/chunks/polyfills-c67a75d1b6f99dc8.js\"></script><script async=\"\" src=\"https://cdn.theatlantic.com/_next/static/chunks/6449.64aa63d8dc3c0934.js\"></script><script async=\"\" src=\"https://cdn.theatlantic.com/_next/static/chunks/2839.28ced1947611cbe2.js\"></script><script src=\"https://cdn.theatlantic.com/_next/static/chunks/webpack-4e2a44befefca0f2.js\" async=\"\"></script><script src=\"https://cdn.theatlantic.com/_next/static/chunks/framework-2114f3935436c3d0.js\" async=\"\"></script><script src=\"https://cdn.theatlantic.com/_next/static/chunks/main-1eeac463cdc5af3a.js\" async=\"\"></script><script src=\"https://cdn.theatlantic.com/_next/static/chunks/pages/_app-0c4cdb774f4267b1.js\" async=\"\"></script><script src=\"https://cdn.theatlantic.com/_next/static/chunks/6729-85e40cec85603df8.js\" async=\"\"></script><script src=\"https://cdn.theatlantic.com/_next/static/chunks/5303-aee0b269eb8bb8f8.js\" async=\"\"></script><script src=\"https://cdn.theatlantic.com/_next/static/chunks/2746-64955f9340e528e6.js\" async=\"\"></script><script src=\"https://cdn.theatlantic.com/_next/static/chunks/1902-8f8938b0370f1477.js\" async=\"\"></script><script src=\"https://cdn.theatlantic.com/_next/static/chunks/2739-71109d77017fa907.js\" async=\"\"></script><script src=\"https://cdn.theatlantic.com/_next/static/chunks/3634-14d031932913845a.js\" async=\"\"></script><script src=\"https://cdn.theatlantic.com/_next/static/chunks/9712-ed128833df024aa9.js\" async=\"\"></script><script src=\"https://cdn.theatlantic.com/_next/static/chunks/4634-85677810286a9f26.js\" async=\"\"></script><script src=\"https://cdn.theatlantic.com/_next/static/chunks/6759-ec3b029465507e70.js\" async=\"\"></script><script src=\"https://cdn.theatlantic.com/_next/static/chunks/4348-d7f32ff2e6db85e4.js\" async=\"\"></script><script src=\"https://cdn.theatlantic.com/_next/static/chunks/5145-8410897236b0d0f4.js\" async=\"\"></script><script src=\"https://cdn.theatlantic.com/_next/static/chunks/7455-cf562e1d1a46e22a.js\" async=\"\"></script><script src=\"https://cdn.theatlantic.com/_next/static/chunks/7124-2a8540ed513c75a5.js\" async=\"\"></script><script src=\"https://cdn.theatlantic.com/_next/static/chunks/393-e6ccecd668f397ae.js\" async=\"\"></script><script src=\"https://cdn.theatlantic.com/_next/static/chunks/pages/%5Bchannel%5D/archive/%5Byear%5D/%5Bmonth%5D/%5Bslug%5D/%5Bid%5D-ace40525ba90f8db.js\" async=\"\"></script><script src=\"https://cdn.theatlantic.com/_next/static/0b2c874c71/_buildManifest.js\" async=\"\"></script><script src=\"https://cdn.theatlantic.com/_next/static/0b2c874c71/_ssgManifest.js\" async=\"\"></script></body></html>","oembed":false,"readabilityObject":{"title":"America’s COVID-Booster Rates Are a Bad Sign for Winter","content":"<div id=\"readability-page-1\" class=\"page\"><article><header data-event-module=\"hero\"><div><div><p><h2 data-flatplan-title=\"true\">It’s a Bad Time to Be a Booster Slacker</h2></p><p>Americans aren’t getting the new bivalent COVID shot. What does that mean for the looming winter wave?</p></div><div><figure><div data-flatplan-lead_figure_media=\"true\"><picture><img alt=\"An image of a pair of gloved hands inserting a syringe into a vaccine vial\" sizes=\"(min-width: 976px) 976px, 100vw\" srcset=\"https://cdn.theatlantic.com/thumbor/ypadUpmVZasWiH0UK19UIWCk-DY=/0x0:3997x2248/750x422/media/img/mt/2022/10/original-5/original.jpg 750w, https://cdn.theatlantic.com/thumbor/UjW1EycehV4idraMjXXTUzdzM3Y=/0x0:3997x2248/828x466/media/img/mt/2022/10/original-5/original.jpg 828w, https://cdn.theatlantic.com/thumbor/v0GNZffQTN6fPf-jrigYoEaENJ8=/0x0:3997x2248/960x540/media/img/mt/2022/10/original-5/original.jpg 960w, https://cdn.theatlantic.com/thumbor/_VN9lLez7t_KGDXf5AFrwYIjXH0=/0x0:3997x2248/976x549/media/img/mt/2022/10/original-5/original.jpg 976w, https://cdn.theatlantic.com/thumbor/iRjqgy5ntF48AWXHpMjk2PCkLuM=/0x0:3997x2248/1952x1098/media/img/mt/2022/10/original-5/original.jpg 1952w\" src=\"https://cdn.theatlantic.com/thumbor/v0GNZffQTN6fPf-jrigYoEaENJ8=/0x0:3997x2248/960x540/media/img/mt/2022/10/original-5/original.jpg\" id=\"article-lead-image\" width=\"960\" height=\"540\"></picture></div><figcaption data-flatplan-lead_figure_caption=\"true\">DANIEL LEAL / AFP / Getty</figcaption></figure></div></div><gpt-ad format=\"injector\" sizes-at-0=\"mobile-wide\" targeting-pos=\"injector-article-start\" sizes-at-976=\"desktop-wide\"></gpt-ad></header><section data-event-module=\"article body\" data-flatplan-body=\"true\"><p data-flatplan-paragraph=\"true\">And just like that, with the passing of Labor Day, fall was upon us. Seemingly overnight, six-packs of pumpkin beer materialized on grocery shelves, hordes of city dwellers descended upon apple orchards—and America rolled out new COVID boosters. The timing wasn’t a coincidence. Since the beginning of the pandemic, cases in North America and Europe have risen during the fall and winter, and there was no reason to expect anything different this year. Spreading during colder weather is simply what respiratory diseases like COVID do. The hope for the fall booster rollout was that Americans would take it as an opportunity to supercharge their immunological defenses against the coronavirus in advance of a winter wave that <em>we know is going to come</em>.</p><p data-flatplan-paragraph=\"true\">So far, reality isn’t living up to that hope. Since the new booster became available in early September, <a data-event-element=\"inline link\" href=\"https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-people-second-booster-pop50\">fewer than 20 million Americans</a> have gotten the shot, according to the CDC—just 8.5 percent of those who are eligible. The White House COVID-19 response coordinator, Ashish Jha, said at a <a data-event-element=\"inline link\" href=\"https://www.whitehouse.gov/briefing-room/press-briefings/2022/10/11/press-briefing-by-press-secretary-karine-jean-pierre-and-covid-19-response-coordinator-dr-ashish-jha-5/\">press conference earlier this month</a> that he expects booster uptake to increase in October as the temperatures drop and people start taking winter diseases more seriously. That doesn’t seem to be happening yet. America’s booster campaign is going so badly that by late September, <a data-event-element=\"inline link\" href=\"https://www.kff.org/coronavirus-covid-19/press-release/half-of-public-has-heard-little-or-nothing-about-the-new-covid-19-booster-aimed-at-omicron-many-dont-know-if-the-cdc-recommends-that-they-get-the-new-booster/\">only half of Americans had heard even “some”</a> information about the bivalent boosters, according to a recent survey. The low numbers are especially unfortunate because the remaining 91.5 percent of booster-eligible people have already shown that they’re open to vaccines by getting at least their first two shots—if not already at least one booster.</p><p data-flatplan-paragraph=\"true\">Now the bungled booster rollout could soon run headfirst into the winter wave. The virus is not yet surging in the United States—at least as far as we can tell—but as the weather cools down, cases have been on the rise in <a data-event-element=\"inline link\" href=\"https://www.theatlantic.com/health/archive/2022/10/europe-covid-cases-variants-winter-surge/671807/\">Western Europe</a>, which has previously foreshadowed what happens in the U.S. At the same time, new Omicron offshoots such as <a data-event-element=\"inline link\" href=\"https://covid.cdc.gov/covid-data-tracker/#variant-proportions\">BQ.1 and BQ.1.1</a> are gaining traction in the U.S., and others, including XBB, are creating problems in Singapore. Boosters are our best chance at protecting ourselves from getting swept up in whatever this virus throws at us next, but too few of us are getting them. What will happen if that doesn’t change?</p><p data-flatplan-paragraph=\"true\">The whole reason for new shots is that though the protection conferred by the original vaccines is tremendous, it has waned <a data-event-element=\"inline link\" href=\"https://www.cdc.gov/mmwr/volumes/71/wr/mm7142a3.htm\">over time and with new variants</a>. The latest booster, which is called “bivalent” because it targets both the original SARS-CoV-2 virus and BA.5, is meant to <a data-event-element=\"inline link\" href=\"https://www.biorxiv.org/content/10.1101/2022.09.21.508818v1.full\">kick-start</a> the production of more neutralizing antibodies, which in turn should prevent new infection in the short term, Katelyn Jetelina, a public-health expert who writes the newsletter <a data-event-element=\"inline link\" href=\"https://yourlocalepidemiologist.substack.com/\">Your Local Epidemiologist</a>, told me. The other two goals for the vaccine are still being studied: The hope is that it will also <a data-event-element=\"inline link\" href=\"https://www.nature.com/articles/d41586-022-03119-3\">broaden protection</a> by teaching the immune system to recognize other aspects of the virus, and that it will make protection longer-lasting.</p><p data-flatplan-paragraph=\"true\">In theory, this souped-up booster would make a big difference heading into another wave. In September, a <a data-event-element=\"inline link\" href=\"https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2022-09-01/08-COVID-Oliver-508.pdf\">forecast</a> presented by the Advisory Committee on Immunization Practices (ACIP), which advises the CDC, showed that if people get the bivalent booster at the same rate as they do the flu vaccine—optimistic, given that about 50 percent of people have gotten the flu vaccine in recent years—roughly 25 million infections, 1 million hospitalizations, and 100,000 deaths could be averted by the end of March 2023.</p><p data-flatplan-paragraph=\"true\">But these numbers shouldn’t be taken as gospel, because protection across the population varies widely and modeling can’t account for all of the nuance that happens in real life. Gaming out exactly what our dreadful booster rates mean going forward is not a simple endeavor “given that the immune landscape is becoming more and more complex,” Jetelina told me. People received their first shots and boosters at different times, if they got them at all. And the same is true of infections over the past year, with the added wrinkle that those who fell sick all didn’t get the same type of Omicron. All of these factors play a role in how much America’s immunological guardrails will hold up in the coming months. “But it’s very clear that a high booster rate would certainly help this winter,” Jetelina said.</p><p data-flatplan-paragraph=\"true\">At this point in the pandemic, getting COVID is far less daunting for healthy people than it was a year or two ago (although the prospect of developing long COVID still looms). The biggest concerns are hospitalizations and deaths, which make low booster uptake among vulnerable groups such as the elderly and immunocompromised especially worrying. That said, everyone ages 5 and up who has received their primary vaccine is encouraged to get the new booster. It bears repeating that vaccination not only protects against severe illness and death but has the secondary effect of preventing transmission, thereby reducing the chances of infecting the vulnerable.</p><p data-flatplan-paragraph=\"true\">What will happen next is hard to predict, Michael Osterholm, an epidemiologist at the University of Minnesota, told me, but now is a bad time for booster rates to be this low. Conditions are ripe for COVID’s spread. Protection is waning among the unboosted, immunity-dodging variants are emerging, and Americans just don’t seem to care about COVID anymore, Osterholm explained. The combination of these factors, he said, is “not a pretty picture.” By skipping boosters, people are missing out on the chance to offset these risks, though non-vaccine interventions such as masking and ventilation improvements can help too.</p><p data-flatplan-paragraph=\"true\">That’s not to say that the immunity conferred by vaccination and the initial boosters is moot. Earlier doses still offer “pretty substantial protection,” Saad Omer, a Yale epidemiologist, told me. Not only are eligible Americans slacking on booster uptake, but lately vaccine uptake among the unvaccinated hasn’t risen much either. Before the new bivalent shots came around, less than half of eligible Americans had gotten a booster. “That means we are, as a population, much more vulnerable going into this fall,” James Lawler, an infectious-diseases expert at the University of Nebraska Medical Center, told me.</p><p data-flatplan-paragraph=\"true\">If booster uptake—and vaccine uptake overall—remains low, expecting more illness, particularly among the vulnerable, would be reasonable, William Schaffner, a professor of infectious diseases at Vanderbilt University Medical Center, told me. Hospitalizations will rise more than they would otherwise, and with them the stress on the health-care system, which will also be grappling with the <a data-event-element=\"inline link\" href=\"https://www.cdc.gov/flu/about/burden/index.html\">hundreds of thousands of people</a> likely to be hospitalized for flu. While Omicron causes relatively minor symptoms, “it’s quite capable of producing severe disease,” Schaffner said. Since August, it has killed an average of <a data-event-element=\"inline link\" href=\"https://coronavirus.jhu.edu/region/united-states\">300 to 400 people each day</a>.</p><p data-flatplan-paragraph=\"true\">All of this assumes that we won’t get a completely new variant, of course. So far, the BA.5 subvariant targeted by the bivalent booster is still dominating cases around the world. Newer ones, such as XBB, BQ.1.1, and BQ.1, are steadily gaining traction, but they’re still offshoots of Omicron. “We’re still very hopeful that the booster will be effective,” Jetelina said. But the odds of what she called an “Omicron-like event,” in which a completely new SARS-CoV-2 lineage—one that warrants a new Greek letter—emerges out of left field, are about 20 to 30 percent, she estimated. Even in this case, the bivalent nature of the booster would come in handy, helping protect against a wider crop of potential variants. The effectiveness of our shots against a brand-new variant depends on its mutations, and how much they overlap with those we’ve already seen, so “we’ll see,” Omer said.</p><p data-flatplan-paragraph=\"true\">Just as it isn’t too late to get boosted, there’s still time to improve uptake in advance of a wave. If you’re <a data-event-element=\"inline link\" href=\"https://www.theatlantic.com/health/archive/2022/08/fall-covid-vaccine-new-booster-shot-omicron/671265/\">three to six months</a> out from an infection or your last shot, the best thing you can do for your immune system right now is to get another dose, and do it soon. Though there’s no perfect and easy solution that can overcome widespread vaccine fatigue, that doesn’t mean trying isn’t worthwhile. “Right now, we don’t have a lot of people that feel the pandemic is that big of a problem,” and people are more likely to get vaccinated if they feel their health is challenged, Osterholm said.</p><p data-flatplan-paragraph=\"true\">There’s also plenty of room to crank the volume on the messaging in general: Not long ago, the initial vaccine campaign involved blasting social media with <a data-event-element=\"inline link\" href=\"https://www.vulture.com/2021/03/celebrities-who-got-the-covid-19-vaccine.html\">celebrity endorsers</a> such as Dolly Parton and Olivia Rodrigo. Where is that now? Lots of pharmacies are swimming in vaccines, but making getting boosted even easier and more convenient can go a long way too. “We need to catch them where they come,” said Omer, who thinks boosters should be offered at workplaces, in churches and community centers, and at specialty clinics such as dialysis centers where patients are vulnerable by default.</p><p data-flatplan-paragraph=\"true\">After more than two years of covering and living through the pandemic, believe me: I get that people are over it. It’s easy not to care when the risks of COVID seem to be negligible. But while shedding masks is one thing, taking a blasé attitude toward boosters is another. Shots alone can’t solve all of our pandemic problems, but their unrivaled protective effects are fading. Without a re-up, when the winter wave reaches U.S. shores and more people start getting sick, the risks may no longer be so easy to ignore.</p></section><gpt-ad format=\"injector\" sizes-at-0=\"mobile-wide,native,house\" targeting-pos=\"injector-most-popular\" sizes-at-976=\"desktop-wide,native,house\"></gpt-ad></article></div>","textContent":"It’s a Bad Time to Be a Booster SlackerAmericans aren’t getting the new bivalent COVID shot. What does that mean for the looming winter wave?DANIEL LEAL / AFP / GettyAnd just like that, with the passing of Labor Day, fall was upon us. Seemingly overnight, six-packs of pumpkin beer materialized on grocery shelves, hordes of city dwellers descended upon apple orchards—and America rolled out new COVID boosters. The timing wasn’t a coincidence. Since the beginning of the pandemic, cases in North America and Europe have risen during the fall and winter, and there was no reason to expect anything different this year. Spreading during colder weather is simply what respiratory diseases like COVID do. The hope for the fall booster rollout was that Americans would take it as an opportunity to supercharge their immunological defenses against the coronavirus in advance of a winter wave that we know is going to come.So far, reality isn’t living up to that hope. Since the new booster became available in early September, fewer than 20 million Americans have gotten the shot, according to the CDC—just 8.5 percent of those who are eligible. The White House COVID-19 response coordinator, Ashish Jha, said at a press conference earlier this month that he expects booster uptake to increase in October as the temperatures drop and people start taking winter diseases more seriously. That doesn’t seem to be happening yet. America’s booster campaign is going so badly that by late September, only half of Americans had heard even “some” information about the bivalent boosters, according to a recent survey. The low numbers are especially unfortunate because the remaining 91.5 percent of booster-eligible people have already shown that they’re open to vaccines by getting at least their first two shots—if not already at least one booster.Now the bungled booster rollout could soon run headfirst into the winter wave. The virus is not yet surging in the United States—at least as far as we can tell—but as the weather cools down, cases have been on the rise in Western Europe, which has previously foreshadowed what happens in the U.S. At the same time, new Omicron offshoots such as BQ.1 and BQ.1.1 are gaining traction in the U.S., and others, including XBB, are creating problems in Singapore. Boosters are our best chance at protecting ourselves from getting swept up in whatever this virus throws at us next, but too few of us are getting them. What will happen if that doesn’t change?The whole reason for new shots is that though the protection conferred by the original vaccines is tremendous, it has waned over time and with new variants. The latest booster, which is called “bivalent” because it targets both the original SARS-CoV-2 virus and BA.5, is meant to kick-start the production of more neutralizing antibodies, which in turn should prevent new infection in the short term, Katelyn Jetelina, a public-health expert who writes the newsletter Your Local Epidemiologist, told me. The other two goals for the vaccine are still being studied: The hope is that it will also broaden protection by teaching the immune system to recognize other aspects of the virus, and that it will make protection longer-lasting.In theory, this souped-up booster would make a big difference heading into another wave. In September, a forecast presented by the Advisory Committee on Immunization Practices (ACIP), which advises the CDC, showed that if people get the bivalent booster at the same rate as they do the flu vaccine—optimistic, given that about 50 percent of people have gotten the flu vaccine in recent years—roughly 25 million infections, 1 million hospitalizations, and 100,000 deaths could be averted by the end of March 2023.But these numbers shouldn’t be taken as gospel, because protection across the population varies widely and modeling can’t account for all of the nuance that happens in real life. Gaming out exactly what our dreadful booster rates mean going forward is not a simple endeavor “given that the immune landscape is becoming more and more complex,” Jetelina told me. People received their first shots and boosters at different times, if they got them at all. And the same is true of infections over the past year, with the added wrinkle that those who fell sick all didn’t get the same type of Omicron. All of these factors play a role in how much America’s immunological guardrails will hold up in the coming months. “But it’s very clear that a high booster rate would certainly help this winter,” Jetelina said.At this point in the pandemic, getting COVID is far less daunting for healthy people than it was a year or two ago (although the prospect of developing long COVID still looms). The biggest concerns are hospitalizations and deaths, which make low booster uptake among vulnerable groups such as the elderly and immunocompromised especially worrying. That said, everyone ages 5 and up who has received their primary vaccine is encouraged to get the new booster. It bears repeating that vaccination not only protects against severe illness and death but has the secondary effect of preventing transmission, thereby reducing the chances of infecting the vulnerable.What will happen next is hard to predict, Michael Osterholm, an epidemiologist at the University of Minnesota, told me, but now is a bad time for booster rates to be this low. Conditions are ripe for COVID’s spread. Protection is waning among the unboosted, immunity-dodging variants are emerging, and Americans just don’t seem to care about COVID anymore, Osterholm explained. The combination of these factors, he said, is “not a pretty picture.” By skipping boosters, people are missing out on the chance to offset these risks, though non-vaccine interventions such as masking and ventilation improvements can help too.That’s not to say that the immunity conferred by vaccination and the initial boosters is moot. Earlier doses still offer “pretty substantial protection,” Saad Omer, a Yale epidemiologist, told me. Not only are eligible Americans slacking on booster uptake, but lately vaccine uptake among the unvaccinated hasn’t risen much either. Before the new bivalent shots came around, less than half of eligible Americans had gotten a booster. “That means we are, as a population, much more vulnerable going into this fall,” James Lawler, an infectious-diseases expert at the University of Nebraska Medical Center, told me.If booster uptake—and vaccine uptake overall—remains low, expecting more illness, particularly among the vulnerable, would be reasonable, William Schaffner, a professor of infectious diseases at Vanderbilt University Medical Center, told me. Hospitalizations will rise more than they would otherwise, and with them the stress on the health-care system, which will also be grappling with the hundreds of thousands of people likely to be hospitalized for flu. While Omicron causes relatively minor symptoms, “it’s quite capable of producing severe disease,” Schaffner said. Since August, it has killed an average of 300 to 400 people each day.All of this assumes that we won’t get a completely new variant, of course. So far, the BA.5 subvariant targeted by the bivalent booster is still dominating cases around the world. Newer ones, such as XBB, BQ.1.1, and BQ.1, are steadily gaining traction, but they’re still offshoots of Omicron. “We’re still very hopeful that the booster will be effective,” Jetelina said. But the odds of what she called an “Omicron-like event,” in which a completely new SARS-CoV-2 lineage—one that warrants a new Greek letter—emerges out of left field, are about 20 to 30 percent, she estimated. Even in this case, the bivalent nature of the booster would come in handy, helping protect against a wider crop of potential variants. The effectiveness of our shots against a brand-new variant depends on its mutations, and how much they overlap with those we’ve already seen, so “we’ll see,” Omer said.Just as it isn’t too late to get boosted, there’s still time to improve uptake in advance of a wave. If you’re three to six months out from an infection or your last shot, the best thing you can do for your immune system right now is to get another dose, and do it soon. Though there’s no perfect and easy solution that can overcome widespread vaccine fatigue, that doesn’t mean trying isn’t worthwhile. “Right now, we don’t have a lot of people that feel the pandemic is that big of a problem,” and people are more likely to get vaccinated if they feel their health is challenged, Osterholm said.There’s also plenty of room to crank the volume on the messaging in general: Not long ago, the initial vaccine campaign involved blasting social media with celebrity endorsers such as Dolly Parton and Olivia Rodrigo. Where is that now? Lots of pharmacies are swimming in vaccines, but making getting boosted even easier and more convenient can go a long way too. “We need to catch them where they come,” said Omer, who thinks boosters should be offered at workplaces, in churches and community centers, and at specialty clinics such as dialysis centers where patients are vulnerable by default.After more than two years of covering and living through the pandemic, believe me: I get that people are over it. It’s easy not to care when the risks of COVID seem to be negligible. But while shedding masks is one thing, taking a blasé attitude toward boosters is another. Shots alone can’t solve all of our pandemic problems, but their unrivaled protective effects are fading. Without a re-up, when the winter wave reaches U.S. shores and more people start getting sick, the risks may no longer be so easy to ignore.","length":9668,"excerpt":"Americans aren’t getting the new bivalent COVID shot. What does that mean for the looming winter wave?","byline":"Yasmin Tayag","dir":"ltr","siteName":"The Atlantic","lang":"en"},"finalizedMeta":{"title":"It’s a Bad Time to Be a Booster Slacker","description":"Americans aren’t getting the new bivalent COVID shot. What does that mean for the looming winter wave?","author":false,"creator":"Yasmin Tayag","publisher":false,"date":"2022-10-26T11:26:26Z","subject":"Health","topics":["new COVID boosters","fall booster rollout","new booster","late September","much America’s immunological guardrails","early September","booster uptake","bivalent boosters","immune system","booster-eligible people","best chance","severe illness","original vaccines","new infection","coming months","America’s booster campaign","vulnerable groups","original SARS-CoV-2 virus","six-packs of pumpkin beer","Omicron causes","flu vaccine","community centers","pandemic problems","low numbers","North America","big difference","best thing","respiratory diseases","secondary effect","recent years","new Omicron offshoots","combination of these factors","White House COVID-19 response coordinator","people","new shots","lot of people","healthy people","vaccines","Advisory Committee","recent survey","latest booster","bivalent booster","United States","apple orchards","press conference","public-health expert","past year","Western Europe","short term","social media","health","Health"]},"jsonLd":{"@type":"WebSite","headline":false,"description":false,"image":[],"mainEntityOfPage":{"@type":false,"@id":false},"datePublished":false,"dateModified":false,"isAccessibleForFree":false,"isPartOf":{"@type":[],"name":false,"productID":false},"discussionUrl":false,"license":false,"author":{"@type":false,"name":false,"description":false,"sameAs":false,"image":{"@type":false,"url":false},"givenName":false,"familyName":false,"alternateName":false,"publishingPrinciples":false},"publisher":{"@type":false,"name":false,"description":false,"sameAs":false,"logo":{"@type":false,"url":false},"publishingPrinciples":false},"editor":{"@type":false,"name":false,"description":false,"sameAs":false,"image":{"@type":false,"url":false},"givenName":false,"familyName":false,"alternateName":false,"publishingPrinciples":false},"@context":"https://schema.org","name":"The Atlantic","url":"https://www.theatlantic.com","inLanguage":"en-US","issn":"1072-7825","potentialAction":{"@type":"SearchAction","target":"https://www.theatlantic.com/search/?q={q}","query-input":"required name=q"}},"twitterObj":false,"status":200,"metadata":{"author":"Yasmin Tayag","title":"America’s COVID-Booster Rates Are a Bad Sign for Winter - The Atlantic","description":"Americans aren’t getting the new bivalent COVID shot. What does that mean for the looming winter wave?","canonical":"https://www.theatlantic.com/health/archive/2022/10/americas-covid-booster-rates-are-a-bad-sign-for-winter/671860/","keywords":["new COVID boosters","fall booster rollout","new booster","late September","much America’s immunological guardrails","early September","booster uptake","bivalent boosters","immune system","booster-eligible people","best chance","severe illness","original vaccines","new infection","coming months","America’s booster campaign","vulnerable groups","original SARS-CoV-2 virus","six-packs of pumpkin beer","Omicron causes","flu vaccine","community centers","pandemic problems","low numbers","North America","big difference","best thing","respiratory diseases","secondary effect","recent years","new Omicron offshoots","combination of these factors","White House COVID-19 response coordinator","people","new shots","lot of people","healthy people","vaccines","Advisory Committee","recent survey","latest booster","bivalent booster","United States","apple orchards","press conference","public-health expert","past year","Western Europe","short term","social media"],"image":"https://cdn.theatlantic.com/_next/static/images/nav-archive-promo-5541b02ae92f1a9276249e1c6c2534ee.png","firstParagraph":"Americans aren’t getting the new bivalent COVID shot. What does that mean for the looming winter wave?"},"dublinCore":{},"opengraph":{"title":"It’s a Bad Time to Be a Booster Slacker","description":"Americans aren’t getting the new bivalent COVID shot. What does that mean for the looming winter wave?","url":"https://www.theatlantic.com/health/archive/2022/10/americas-covid-booster-rates-are-a-bad-sign-for-winter/671860/","site_name":"The Atlantic","locale":"en_US","type":"article","typeObject":{"published_time":"2022-10-25T18:27:00Z","modified_time":"2022-10-26T11:26:26Z","author":false,"publisher":"https://www.facebook.com/TheAtlantic/","section":"Health","tag":"health","opinion":"false","content_tier":"metered"},"image":"https://cdn.theatlantic.com/thumbor/V0abThj5aTxkiLt_4gWCHjDGwk0=/0x5:3996x2086/1200x625/media/img/mt/2022/10/original-5/original.jpg"},"twitter":{"site":"@theatlantic","description":false,"card":false,"creator":false,"title":false,"image":false,"domain":"theatlantic.com"},"archivedData":{"link":false,"wayback":false}}}